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'Avant Propos' 
It is common knowledge of the 21st  century that metozoan cells have the capability to 
undergo programmed cell death (PCD) and that cellular survival is sometimes 
dependent on the repression or activation of this self-destruction program. It is 
exactly four decades ago, in 1963, that Richard Lockshim first reported the term 
"programmed cell death", nine years later the Greek term APOPTOSIS' was 
adopted to designate PCD. 
I became very interested in the study of apoptosis while pursuing my Masters studies 
at Bradford University. One of our assignments was to write a review about a recent 
booming topic in molecular biology and it was then that my attention was directly 
caught by the amazing field of apoptosis. Soon after I felt that I would like to grasp a 
deeper understanding in the field of cell death and especially its molecular 
mechanism. I was fortunate enough to apply and to be accepted for a Ph.D. in 
Professor William Earnshaw's laboratory. Apoptotic research in the Earnshaw 
research group started with the findings of Dr. Edgar Wood, a former postdoc in 
Professor Earnshaw's laboratory in 1989. Dr Wood's so called "mitotic" extracts 
prepared for a cell free experiment had a rather unusual effect when added to isolated 
nuclei. These nuclei were undergoing apoptotic morphology as recognised by Dr 
Yuri Lazebnik. Since then, work conducted in the Earnshaw laboratory has provided 
deeper understanding in the molecular, genetic and cellular mechanisms underlying 
cell death. My work began with an ongoing caspase-6 knockout project and in my 
second year of graduate studies I started a caspase-7 knockout project which 
constituted the major part of my Ph.D. research studies. 
This thesis, divided into five chapters, is a portrayal of the generation and 
characterisation of caspase-6 and caspase-7 deficient DT40 cells. Chapter I is an 
overview of apoptosis starting by a brief historic synopsis on the discovery of cell 
death proceeding to a summery on the progress made so far in the understanding of 
the molecular basis of apoptosis and moving on to introduce the Ph.D. projects and 
the DT40 system used for the generation of deficient cells. Chapter II is a detailed 
description of the materials, methods and protocols used. Chapter III begins with the 
characterisation of the caspase-6 and caspase-7 loci and ends with the design of 
replacement vectors. Chapter IV is allocated to examination of caspase-6 cells and 
chapter V to the analysis of caspase-7 cells. Finally, this thesis ends by a general 
conclusion and future recommendations. 
The word apoptosis "falling off' or "dropping off' in Greek (apO = from, ptOsis = a fall), previously used to describe 
the dropping off of the leaves from trees in the autumn was suggested by James Cormac, Professor of Classical 
Greek at the University of Aberdeen (reviewed in Cummings et al., 1997) 
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Abstract 
Apoptosis, also known as programmed cell death, is an evolutionarily conserved 
mechanism by which the organism removes unwanted cells. The process is common to 
somatic as well as germ cells. It is actively involved in development and morphogenesis, 
cell number control and removal of infected, mutated or damaged cells. Many insights on 
the activation of final triggers and pathways in apoptosis came from genetic studies of 
apoptosis using the worm, C.elegans This work showed that the worm Ced-3 is a protease 
of pivotal role in apoptosis of C.elegans. The mammalian counterparts of CED-3 have 
been identified as members of a family of intracellular proteases that form the core of the 
apoptotic machinery. Since these are cysteine proteases that cleave cellular substrates at 
specific aspartate residues, they were all termed caspases. 
In the last ten years natural and synthetic inhibitors and genetic approaches have been 
used to study elucidate specific caspase function. An alternative system is gene disruption 
in the chicken DT40 cell line. These cells have a high homologous recombination rate 
that facilitates the isolation of knockout alleles. The aim of my project is the genetic 
analysis of caspase-6 and -7 function. My work started with an ongoing caspase-6 
knockout project along with a senior postdoctoral scientist in our lab, Dr Sandrine 
Ruchaud. Subsequently, I concentrated my work on the caspase-7 knockout poject. I 
generated DT40 cell line where both alleles of caspase-6 and —7 were disrupted 
independently. 
Caspase-6: No obvious morphological differences were observed in the apoptotic process 
in caspase-6 deficient cells compared to the wild type. However, examination of 
apoptosis in a cell free system revealed a block in chromatin condensation and apoptotic 
body formation when nuclei from HeLa cells expressing lamin A or lamin A-transfected 
Jurkat cells were incubated in caspase-6 deficient apoptotic extracts. Transfection of 
exogenous caspase-6 into the clone reversed this phenotype. Lamins A and C, which are 
caspase-6-only substrates, were cleaved by the wild type and heterozygous apoptotic 
extracts but not by the extracts lacking caspase-6. Furthermore, the caspase-6 inhibitor z-
VEID-fmk mimicked the effects of caspase-6 deficiency and prevented the cleavage of 
lamin A. Taken together these observations indicate that caspase-6 activity is essential 
for lamin A cleavage and that when lamin A is present, it must be cleaved in order for the 
chromosomal DNA to undergo complete condensation during apoptotic execution. 
Caspase-7: Viability assays showed that caspase-7' clones are more resistant to 
common apoptosis-inducing drugs such as etoposide and staurosporine. Further 
examination of the apoptotic process revealed that caspase-7 cells show a delay in 
phosphatidylserine externalization and DNA fragmentation as well as cleavage of the 
caspase substrates PARP and lamins BI and B2. Caspase affinity labeling and activity 
assays indicated that deficient cells exhibit a delay in caspase activation when compared 
to wild type DT40 cells, providing an explanation for the differences in apoptotic 
execution between caspase-7 null and wild type DT40 cells. These results strongly 
suggest that caspase-7 is involved earlier than other effector caspases in the apoptotic 
execution process in DT40 B lymphocytes. 
My results have provided important new insights into the function of caspase-6 and 
caspase-7 during apoptotic execution. 
Off 
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Chapter I: Introduction 
Apoptosis, also known as programmed cell death, is an evolutionarily conserved 
mechanism by which the organism removes unwanted cells. The process is common 
to somatic as well as germ cells (Kerr et at., 1972; Print and Loveland, 2000). It is 
actively involved in development and morphogenesis, cell number control and 
removal of infected, mutated or damaged cells (Guo and Bruce, 1999). Thus, 
apoptosis is a critical process for the health of every multicellular organism. 
Disregulation in programmed cell death can cause many diseases. Too little apoptosis 
may lead to cancer or autoimmune diseases; too much can induce neurodegenerative 
diseases such as Alzheimer's (LeBlanc et al., 1999). 
I A. A brief history of programmed cell death 
The first reference to developmental cell death dates back to the mid 19th  century 
when Vogt, in 1842, reported death of notochord and adjacent cartilage of 
metamorphic toads (Vogt, 1842). However, Vogt abandoned his curiosity in the field 
of cell death and for decades this new oddity remained silent until Flemming, in 1885, 
presented the first morphological descriptions of naturally occurring cell death (Fig 
1.1A) (Flemming, 1885). Flemming's description was the first to argue that death 
involved chemical changes within the cell. Studying dying granulosa cells of rabbit 
Graafian follicles, Flemming noted an "ill-defined nucleus containing several small, 
heavily stained lumps, and a pale, homogeneous cytoplasm containing what appeared 
to be fine fat droplets". Chromatolysis was the term he proposed and introduced to 
describe cell death observed (Flemming, 1885). Soon after in 1889, Weissmann 
wrote that "higher organisms contain within themselves the germs of death" and by 
the beginning of the 20th  century the concept of intrinsic cell death machinery was 
already acknowledged by many scientists (Weissmann, 1889). Yet, the pioneer for the 
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genetic basis of cell death was the German anatomist Ludvig Graper. In 1914 Graper 
published a paper titled "A new point of view regarding the elimination of cells" with 
the idea that mechanisms must exist to counterbalance mitosis and referring to 
Flemming's chromatolysis (Graper, 1914). Sadly, Graper's publication was 
overlooked and the atypical concept of cell death almost perished (Majno and Joris, 
1995). However, chromatolysis survived among embryologists such as GlUcksmann 
and Saunders who once more stressed on the importance of cell death in development 
such as digit shaping and removal of useless structures (GlUcksmann, 1951). 
The first evidence for the existence of two morphologically distinct types of cell death 
came from an Australian pathologist, John Kerr. In 1965, Kerr was a graduate student 
who focused his Ph.D. studies on hepatocyte atrophy. Whilst studying cytotoxicity in 
the liver, the structural changes he noted did not conform to the established notions of 
cell death. Cells did not display a watery cytoplasm, the intracellular material was not 
released and organelles did not rupture. Instead, the cell lost contact with its 
neighbors, shrunk, nuclear chromatin condensed, membrane bound organelles were 
formed, efficiently phagocytosed and degraded (Kerr et al., 1965). This curious and 
distinct form of liver cell death was first designated as "shrinkage necrosis". 
Subsequently, Kerr and his collaborators Alastair Currie and Andrew Wyllie 
introduced the term apoptosis (see 'Avant Propos') and defined it as a 
"morphologically distinctive, active, inherently controlled form of cell death, 
complementary to mitosis in the regulation of animal cell populations both in 
physiological and pathological conditions" (Fig 1.1B) (Kerr et al., 1972). In 1976 and 
1984, studies on irradiated lymphoid tissues led to the notion that during apoptotic 
cell death chromatin broke down into fragments that produced a DNA ladder (Wyllie 
et al., 1984; Yamada et al., 1981). Since then, studies on apoptosis witnessed an 
explosion and apoptosis research became one of the fastest evolving fields in biology. 
The exploitation of molecular biological techniques led to rapid advances in 
knowledge about programmed cell death in all its aspects including biochemical, 
cellular, genetic and developmental. 
2 
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Fig 1: A, Apoptosis of an overian follicle as figured by Flemming inl88Os 
(Flemming, 1889) B, (a)Transmission electron micrograph of a late-stage 
apoptotic fibroblast. (b) chromatin condensation of an apoptotic fibroblast (C) 
phagocytosed apoptotic body within a phagosome (Wyllie, 1992). 
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I B. Apoptosis research in the molecular era 
1131. 	Morphological changes during apoptosis 
Most of the morphological changes of cell death were observed, characterized and 
described by Kerr over four decades ago in the seminal paper (see above) (Kerr et al., 
1972). As other scientists fascinated by this new phenomenon carried on observing 
dying cells additional characteristics of apoptosis were identified. As a consequence, it 
became widely accepted that at least two types of cell death, distinct in morphology and 
consequences exist, apoptosis, a natural program which is normally silent within the 
host, and necrosis, a form of death that occurs in response to external injury, and that 
leads to exposure of normally sequestered molecules and inflammation (Chautan et al., 
1999; Fiers et al., 1999; Hacker, 2000; Lincz, 1998; Lopez et al., 2003; Matsumura et 
al., 2000; Scheffer et al., 2003; Schwartz et al., 1995). The classical morphological 
characteristics linked to apoptosis are portrayed in Figure 1.2A and include: 
> Cell detachment by the loss of microvilli and gap junctions 
Aggregation of compacted chromatin against the nuclear membrane 
Chromatin DNA fragmentation and break-up of the nucleus into discrete, membrane 
enclosed fragments in which the segregation of compacted chromatin is maintained 
> Cell shrinkage associated with marked convolution of the cell surface to produce 
membrane-bounded apoptotic bodies 
Budding and dispersion of apoptotic bodies 
> Functional and intact mitochondria until the late stages 
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Figure 1.2: Apoptotic morphology 
Fig 1.2: A, Schematic representation of the typical morphological characteristics 
of a dying cell. B, DAR stained apoptotic DT40 nuclei representing the nuclear 
apoptotic events. (a) non-apoptotic. (b) chromatin condensation and 
margination. (d,e) breaking up of the nucleus into discrete, membrane-enclosed 
fragments 
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I B2. Molecular and Cellular Changes 
The observed morphological changes described above are a direct result of biochemical 
modifications occurring in a dying cell. These alterations were revealed with the 
advancement of molecular biology techniques that allowed the characterization and 
identification of apoptotic cells on the molecular level. Two most important changes 
used in the identification of apoptotic cells are the loss of plasma membrane asymmetry, 
leading to phosphatidylserine externalization, and DNA fragmentation. 
I B2a. Phosphatidylserine externalization 
In non-apoptotic cells phosphatidylserine is located in the inner leaflet of the plasma 
membrane. However, early in apoptotic execution, phosphatidylserine becomes 
randomly distributed between the two leaflets (Koopman et al., 1994; Martin et al., 
1995). This event may be a signal to phagocytes (Fadok et al., 1992), yet it is not an 
absolute requirement for macrophage recognition and apoptotic body clearance. 
Phosphatidylserine acts as a pro-coagulant, an effect that is reversed when bound to 
annexin V. Annexin V, belonging to the annexin family of proteins which are 
characterized by their anticoagulant properties, preferentially binds to negatively 
charged phospholipids including phosphatidylserine in the presence of Ca 2+. Annexin V 
binding to the cell membranes can be detected before other apoptotic morphological 
changes take place and before the loss of membrane integrity. Therefore, Annexin V 
bound to a fluorochrome, was established as a useful tool in detecting apoptotic cells and 
is used in quantitative and qualitative studies (Koopman et al., 1994; Vermes et al., 
1995). 
/ B2b. DNA condensation and fragmentation 
In apoptotic cells the nuclear DNA condenses and marginates to the inside of the nuclear 
membrane (Hollis et al., 1987; Lincz, 1998; Morey et al., 1993). Initially, in most (but 
not all cell types) DNA is cleaved into 300 kb and 50 kb fragments, then to 180-200 bp 
internucleosomal fragments which result in a characteristic DNA laddering effect 
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observed by agarose gel electrophoresis (Brown et al., 1993; Wyllie et al., 1987). 
However it is important to point out that, whilst DNA fragmentation is a classical 
marker of apoptosis, it is not required for its execution, for example, apoptosis in the 
MCF-7 breast carcinoma cell line can proceed with no DNA fragmentation (Kagawa et 
at., 2001; Nagata, 2000). 
DNA fragmentation can be easily detected by agarose gel electrophoresis or by a readily 
available and commonly used technique, Terminal deoxynucleotidyl transferase-
mediated dUTP nick labeling (Tunel) staining. The tunel technique detects apoptotic 
cells by using the enzyme terminal deoxynucleotidyl transferase (TdT) to directly label 
the 3'ends of broken DNA strands with a fluorescent base analogue. Similar to annexin 
V staining, Tunel can be used for both quantitative and qualitative analysis (Gavrieli et 
al., 1992). 
I B2c. Acidification of the cytoplasm 
A third cellular change observed in apoptotic cells is cytoplasmic acidification, which is 
recognized as a feature of apoptosis in a variety of systems (Gendron et at., 2001; 
Meisenholder et al., 1996). However, the exact function of this event is still unknown 
and it has not been extensively studied. Some research groups suggested that the change 
in cytoplasmic pH is involved with Bax function(Thangaraju et al., 1999) and caspase 
activation (see Section I Hl) (Furlong et al., 1997; Matsuyama et al., 2000). 
The morphological changes in apoptosis are consequences of interaction, activation and 
inhibition of numerous apoptotic effectors, that interact within and between each other. 
Some effectors have the responsibility to promote cell death whilst others have the task 
of inhibiting apoptosis. Among the most important of the latter is a family of proteolytic 
enzymes known as caspases. 
In the following part of this Introduction, the discussion of apoptosis will focus first on 
caspases and their role in apoptotic execution and second on pathways of caspase 
activation. 
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I C. The biochemistry of cell death: apoptotic execution 
I Cl. Common mechanisms in apoptotic execution 
It is well established that apoptosis occurs in two phases: an initial commitment phase 
followed by an execution phase which involves cytoskeleton distortion, membrane 
blebbing, condensation and fragmentation of chromatin and the formation of apoptotic 
bodies (Boulares et al., 1999; Earnshaw et al., 1999). Significant progress in 
understanding the molecular and biochemical aspects of apoptosis has come from 
genetic studies of developmental cell death in the nematode Caenorhabditis elegans 
(Yuan, 1996). In the course of C. elegans development, 131 of the 1090 cells are 
eliminated in a spatially and temporally organized manner. Initial genetic analysis 
revealed three worm death genes, namely, CED-9 which encode an anti-apoptotic 
regulator, and CED-3 and CED-4, the two worm pro-apoptotic genes (Hengartner, 
1995). Vertebrates have evolved multiple gene families that resemble the C. elegans 
death machinery, each of the nematode genes possesses at least one functional 
equivalent in vertebrates. Indeed, the cell death pathway in C. elegans can be 
considered as a simple model for apoptosis in higher organisms (Hengartner, 1998). 
Mammalian counterparts of CED-3 have been identified as members of a family of 
intracellular proteases called caspases that form the core of the apoptotic machinery 
(Alnemri et al., 1996; Yuan, 1995). These proteolytic enzymes are not only responsible 
for some of the characteristic patterns of cell destruction that mark apoptosis, but also 
for activating themselves, and many other cell death effectors. It is their auto-catalytic 
ability that ensures a prompt and rapid apoptotic execution phase (Earnshaw et al., 1999; 
Fischer et al., 2003; Hengartner, 2000). The only mammalian CED-4 homologue 
identified to date is (Apaf- 1) whereas, the Bcl-2 protein-related family was found to be 
the counterpart for the nematode anti-apoptotic protein CED-9. In higher eukaryotes 
Bcl-2 members can either promote or inhibit apoptosis (see Section I H). 
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I C2. The hallmarks of apoptotic execution 
Studies over the last decade indicate that proteolytic cleavages of key proteins by 
activated caspases are responsible for the accomplishment of the apoptotic morphology. 
In spite of the fact that the exact mechanism of how degradation of these proteins results 
in apoptotic morphology remains unknown, many proteins targeted by caspases 
participate in the formation and regulation of the membrane-associated cortical 
microfilament cytoskeleton, an important determinant of apoptotic cell shape 
(Brancolini et al., 1997; Brown et al., 1997; Mashima et al., 1997; Vanags et al., 1996; 
Wang et al., 1998b). Caspases also cleave protein kinases at the cell-to-cell and cell-to-
matrix attachment sites enhancing pro-apoptotic signaling and possibly cell detachment 
from surrounding tissue (Cardone et al., 1997; Kwan et al., 2001; Rudel and Bokoch, 
1997; Wen et al., 1998). In addition, caspases and their activated substrates are involved 
in the regulation of chromatin condensation and DNA fragmentation. Topoisomerase II 
alpha (Durrieu et al., 2000) and acinus (Sahara et al., 1999) have been shown to have 
roles in apoptotic chromatin condensation. The DNAse enzymes responsible for DNA 
fragmentation during apoptosis include, Caspase Activated DNAse (CAD) (Enari et al., 
1998; Sakahira et al., 1998) and Endonuclease G (Li et al., 2001; Parrish et al., 2001). 
CAD is an apoptosis-specific endonuclease that cleaves DNA into the observed 
olignucleosomal fragments. CAD is found in the nucleus in an inactive complex bound 
to its inhibitor ICAD (Samejima and Earnshaw, 2000). However, ICAD is not just an 
inhibitor but also chaperone for CAD, since active CAD is only expressed in the 
presence of ICAD. The cleavage of ICAD by caspases results in dissolution of the 
complex, CAD activation and DNA degradation (Enari et al., 1998; Sakahira et al., 
1998). However, CAD seems to be required for oligonucleosomal fragmentation but not 
essential for certain classes of high molecular weight DNA cleavage and the early stages 
of apoptotic chromatin condensation in DT40 cells (Samejima et al., 2001). 
A large number of important observations have been made in the field of cell death, 
some of which are stated above, yet the greatest impact on the study of apoptotic 
execution has been the identification of caspases as the executioners of cell death. 
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I D. What are Caspases? 
As stated in Section I Cl, in nematodes CED-3 is critical for C. elegans cell death. 
Cloning and sequencing of CED-3 indicated that it is related to a mammalian protease 
known as interleukin-1--converting enzyme (ICE) (Yuan et al., 1993). ICE was 
recognized for its role in inflammation and studies of ICE concentrated on the need to 
clarify mechanisms for conversion of Pro IL-1 to IL-113,  the highly potent cytokine 
(March et al., 1985; Mosley et al., 1987; Wilson et al., 1994). The discovery of ICE 
homology to nematode CED-3 encouraged scientists to inquire about potential roles for 
ICE in apoptosis, however resulting reports showed that it was not primarily involved in 
cell death, rather ICE main role remained its inflammatory regulatory function (Zeuner 
et al., 1999). On the other hand, subsequent investigation revealed the existence of 
multiple vertebrate CED-3-like homologues, most of which were later shown to function 
primarily in apoptosis (see following sections). Soon after the identification of a number 
of this family of proteases it became apparent that they all share similar functions and 
structure (Eamshaw et al., 1999; Hengartner, 2000). 
A unifying nomenclature was adopted for convenience and to provide a definition for 
this family of proteases. Consequently, the enzymes were designated by 'caspases', an 
abbreviation for gysteine dependent aspartate directed proteases. At present, the 
proteins of this family are individually named caspase-n, where n= the number of the 
caspase in question. Thirteen caspases have been identified to date in humans (Fischer 
et al., 2003; Hu et al., 1998; Koenig et al., 2001), many of them are found to be 
implicated in the apoptosis process (Earnshaw et al., 1999; Fischer et al., 2003; 
Hengartner, 2000; Humke et al., 1998). Consequently, many interesting questions 
concerning their structure, function, inter and intra interactions, regulation by different 
effectors and exact contributions to cell death pathways arose. 
I Dl. Caspase structure 
Caspases are constitutively present in healthy cells as proenzymes. Biochemical studies 
of procaspases have identified three basic domains, the pro-domain, the large subunit 
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(p20), and the small subunit (plO). Caspases share a high substrate specificity whereby 
they cleave target proteins just after an N-terminal Asp residue (P1 site). The domains of 
caspase zymogens are partitioned by Asp-X bonds (Green and Amarante-Mendes, 1998; 
Howard et al., 1991). Caspase activation results after proteolysis and processing of the 
two subunits followed by their association to form a heterodimer (Figure 1.3). The 
crystal structure of active caspases, such as caspase- 1, -3,-7, -8 and —9, showed that they 
exist as a tetrameter of the two heterodimers (Blanchard et al., 1999; Renatus et al., 
2001; Riedl et al., 2001; Wei et al., 2000). The groove resulting from the intimate 
association of the large and small subunits constitute the cysteine-dependent active site 
(Blanchard et al., 1999; Wei et al., 2000) (Fig 1.3) 
I D2. Caspase families 
Although members of the family of caspases share a common structure, there are 
differences that reflect their slightly different roles in apoptosis (could be removed for 
the page break). Depending on the primary structure of their N-terminus, apoptotic 
caspases were grouped into initiator caspases and effector caspases, yet not all caspases 
are involved in apoptosis and a third family exist, mainly involved in inflammation 
(Earnshaw et al., 1999; Lincz, 1998; Raffet al., 1998; Raff, 1992). 
Cytokine processor caspases family (ICE): 
Family members (caspase- 1, -4, -5 and —11) are mainly involved in inflammation. 
Initiator caspase family: 
Caspases in this group contain an extended pro-domains, which allow association with 
receptor complexes for receptor-stimulated apoptosis. Caspase-2 and -9 contain Caspase 
Recruitment Domains (CARDs) and caspase-8 and -10 contain Death effector domains 
(DED5). Initiator caspases generally act upstream of effector caspases. 
Execution caspase family: 
Caspases (caspase-3, -6 and -7) in this group have short, non-functional (except for 
maintaining inactivity) pro-domains. They are responsible for interacting with other 
caspases and non-caspase molecules to induce apoptosis 
11 
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Figure 1.3: Caspase activation 
Initiator caspases 
Small 	i a subunit 
Asp X 	 Asp 	
Inactive proerizyme 
Small Large subnunit 	subunilt 
Proenzyme is cleaved at Effector caspases 	
caspase cleavage site (Asp X) 
Active caspase 
Catalytic sites 
roenzyme is cleaved at 
aspase cleavage site (Asp X) 
Fig 1.3: Schematic representation of caspase activation. (a) caspases with a 
substantial prodomain. (caspase-2, 8, 9, 10), (b) caspases with short 
prodomain (caspase-3, -6 and -7). (see text for detail) 
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1133. Caspase localization 
Caspases have different subcellular localizations depending on their state of activation as 
reported by many research groups (Chandler et al., 1998; Kim et al., 2000a; Zhivotovsky 
et at., 1999; Baliga et al., 2003; Nakagawa et at., 2000; Yoneda et al., 2001) and 
summarized in Table 1.1. 




Mitochondial and cytosolic Microsomal and nuclear 
Caspase-3 Mitochondial and cytosolic Mitochondrial, nuclear and cytosolic 
Caspase-6 Cytosolic and nuclear Nuclear 
Caspase-7 Cytosolic Cytosolic and nuclear 
Caspase-8 Cytosolic Cytosolic 
Caspase-9 Cytosolic and mitochondial Cytosolic and mitochondrial 
Caspase-12 Microsomal Microsomal 
I E.The role of caspases in apoptosis 
I El. The role of caspases in the execution phase of apoptosis 
Inhibition of caspase function by genetic and biochemical means has confirmed that 
caspases play an important role in apoptosis. In particular, effector caspases are reported 
to cleave several types of protein during apoptotic execution (for review see Earnshaw et 
al., 1999; Fisher et al., 2003) which include: 
Abundant cytoplasmic proteins such as adherans junction components, the 
intermediate filament proteins and RNA-binding and ribosomal proteins 
Abundant nuclear proteins, such as the lamins and the nuclear mitotic apparatus 
protein. In particular, it is known that caspase-6 cleaves Lamin A, B and C in the 
mammalian system (Takahashi et al., 1996). 
> Proteins involved in DNA metabolism and repair such as PARP-1 (Poly (ADP-
ribose) Polymerase-1) and DNA topoisomerase II (Kaufmann, 1989b; Nakajima et 
al., 1995). 
Protein kinases, for example, PKCs, focal adhesion protein kinase, the MAPK/ERK 
kinase MEKK1, Rafi and Aktl (Wen et al., 1998; Widmann et al., 1998). 
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Proteins involved in the regulation of the cell cycle and proliferation such as the 
retinoblastoma protein (pRB) and p2 1/Wafi (Gervais et al., 1998). 
Proteins whose cleavage plays a direct role in apoptosis such as caspases themselves 
and members of the Bc12 protein family such as Bcl-2, Bc1XL, Bid and Bax (Fujita 
and Tsuruo, 1998). 
Without a doubt the most studied effector caspase is caspase-3 and it is clear that 
caspase-3 plays a substantial role in cleaving numerous substrates in the apoptotic 
process. Yet, caspase-7 is another caspase with a short prodomain that shares the same 
substrate specificity as caspase-3. In fact, many of the substrates are cleaved by 
caspase-3 can also be efficiently cleaved by caspase-7, suggesting at least partial 
redundancy of the two caspases. In caspase-3-deficient mice caspase-7 activity is 
reported to be upregulated, suggesting that the absence of caspase-3 can be compensated 
by caspase-7 (Fischer et al., 2003). Interestingly, caspase-7 was shown to cleave 
substrates at atypical glutamate motifs. This occurs during cleavage of the cytoplasmic 
tail of TNF-R1, the cardiac myosin light chain vMLC, connexin 45.6 and the 
transcription factor Max (Ethell et al., 2001) (Krippner-Heidenreich et al., 2001). In 
addition, caspase-7 can be autoactivated in an unconventional processing manner where 
the cleavage specificity at aspartic acid is not strictly required for caspase activation. 
For example, procaspase-7 can be activated by serine proteases, for example cathepsin G 
activates caspase-7 by cleaving at a glutamate bond (Zhou et al., 1997). 
The first substrates of Caspase-6 to be identified were the nuclear lamins (Orth et al., 
1996; Takahashi et al., 1996). Both chemical inhibitor studies and a follow-up study in 
which caspase-6 activity was selectively inhibited with the serpin SPI-2 suggested that 
lamin cleavage is required for nuclear disassembly during apoptotic execution (Lazebnik 
et al., 1995a; Takahashi and Earnshaw, 1996). Other substrates reported to be cleaved 
by caspase-6 include cytokeratin 18 (Caulin et al., 1997), focal adhesion kinase (Gervais 
et al., 1998), nuclear mitotic apparatus protein (NuMA) (Hirata et al., 1998), the beta-
amyloid precursor protein (Pellegrini et al., 1999), topoisomerase I (Samejima et al., 
1999), nuclear matrix protein SATB1 (Galande et al., 2001), transcription factor AP-
2alpha (Nyormoi et al., 2001), vimentin (Byun et al., 2001) and huntingtin (Wellington 
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et al., 1998). However as implied above, these substrates are also cleaved by other 
caspases, typically caspase-3 and -7, at other cleavage sites. In fact, the only substrate 
presently thought to be cleaved exclusively by caspase-6 is lamin A/C (Takahashi et al., 
1996). 
I E2. Specific function of some individual caspases 
Several methods were adopted to elucidate caspase function, yet the most commonly 
used approach to examine the exact physiological function of specific caspases is gene 
targeting. Several groups have generated knockout mice, Table 1.2 is a summary of 
some of their findings: 





Immune system resistance to a variety (Kuida et al., 1995; Li et al., 1995; 
of pro-inflammatory treatments, Melnikov et al., 2001; Rowe etal., 
reduced !L I (x and IL 13 processing, 2002) 
renal and liver failure.  
Caspase-2 Normal Neuronal defects (delay in apoptosis), (Bergeron etal., 1998; Troy etal., 
germ cells 2000) 
Caspase-3 Postnatal lethal Impaired brain development, lack of (Carambula et al., 2002; Kuida et al., 
(1-3 weeks) DNA fragmentation and delay in 1996; Pompeiano et al., 2000; Woo et 
apoptosis, hepatocyte cell impairment al., 1999; Woo et al., 1998) 
and ovarian problems  
Caspase-8 Embryonic Heart development failure, impairment (varfolomeev et al., 1998) 
lethal of death receptor pathway (Fas, TNF 
and DR3)  
Caspase-9 Embryonic Brain defect (reduced apoptosis, (Hakem et al., 1998; Kuida etal., 
lethal delayed DNA fragmentation), 1998) 
fibroblast resistance to UV and gamma 
irradiation, reduced cytochrome c- 
_______________  mediated_apoptosis1  
Caspase-1 I Normal resistance to LPS-induced shock. (Kang etal., 2002; Wang etal., 1998c) 
Lymphocytes show a delay in caspase- 
3/-7 activation, defects in thymocytes 
apoptosis and caspase-1 activation is 
impaired  
Caspase-12 Normal Resistance to ER mediated apoptosis (Nakagawa etal., 2000) 
after treatment with befeldin A, 
tunicamycin and thapsigargin  
I F. Caspase activation 
Caspases are enzymes that must be kept under tight control, yet need to be quickly 
activated. Therefore, caspases are regulated at the post-translational level and require 
1  According to Hakem et al., cytochrome c is translocated to the cytosol of Casp9-/- ES cells upon UV stimulation of 
fibroblasts but not after UV irradiation of brain cells (Hakem etal., 1998). 
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processing for their activation. Activation of initiator caspases is mediated by binding 
and interaction with adapter molecules via their prodomain. These prodomains function 
by protein-protein interactions mediating the recruitment of initiator caspases into death 
complexes (Singh et al., 1998). Two types of activation, with independent signaling 
cascades, have been reported. In both pathways the prodomain binds to an adapter 
molecule containing a similar domain. The first, 'induced proximity model' includes 
pro-caspase-8 and —10 activation via the death induced signaling complex in the 
receptor-mediated pathway (Krueger et al., 2001b; Muzio et al., 1998). The second, 
'association with regulatory subunit' involves pro-caspase-9 activation through the 
association with Apaf- 1 in the mitochondrial stress-mediated pathway (Li et al., 1997; 
Rodriguez and Lazebnik, 1999). 
I Fl. 	Major pathways of caspase activation 
I Fla. Death receptor mediated apoptosis 
Vertebrates have evolved a variety of mechanisms enabling them to direct individual 
cells to activate their death pathways. Death receptors, embedded in the plasma 
membrane, can transmit an apoptotic signal that leads to caspase activation within 
seconds (Thornberry, 1998; Thornberry and Lazebnik, 1998). Death receptors are 
members of the tumor necrosis factor (TNF) receptor superfamily that are defined by 
similar, cysteine rich extracellular domains and a cytoplasmic sequence of 80 aa known 
as the death domain (DD). The best characterized death receptors are CD95/Fas and 
TNFR1 (Williams and Smith, 1993; Yonehara et al., 1989). Other death receptors have 
also been identified such as death receptor 3 (DR3), DR4, DR5 and DRb (Chaudhary et 
al., 1997; Schneider et al., 1997; Wiley et al., 1995; Wu et al., 2003). Ligands that bind 
to these death receptors belong to the TNF gene superfamily. Consequently, FasL (Fas 
ligand) binds to Fas and TNF binds to TNFR1 resulting in the initiation of the cell death 
cascade (Ashkenazi and Dixit, 1998). 
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Death signaling by Fas 
This pathway is typically engaged in the immune system and is activated to delete 
activated T-cells at the end of an immune response (O'Connell et al., 2002). Fas/CD95 is 
a 45 kDa protein expressed in activated T cells and NK cells. FasL binding to its 
receptor stabilizes its trimerization resulting in the clustering of the intracellular DD 
followed by the recruitment of Fas-associated death domain (FADD). FADD also 
contains a DD which mediates its association with the oligomerised Fas. This complex 
is called the DISC (Death Inducing Signaling Complex) (Medema et al., 1997). The 
DISC recruits procaspase-8. As more procaspase-8 molecules are clustered, they 
undergo transcatalysis, producing active caspase-8 (Ducoroy et al., 2003 ). The active 
caspase-8 then activates downstream caspases such as procaspase-3, -6 or —7 which in 
turn dismantle the cell (Walczak and Krammer, 2000) (see Fig. 1.4). Recently it was 
suggested that Fas signaling and the formation of the death inducing signaling complex 
is instigated by two adjacent trimeric Fas ligands (Holler et al., 2003). 
Death signaling by TNFR1 
Signaling through TNFR1 is more complex than Fas and involves the activation of 
multiple factors that lead to apoptosis through branched signaling cascades (see Fig 1.4) 
(McFarlane et al., 2002). The apoptotic cascade through TNFR Associated Death 
Domain is very similar to the one through Fas and also involves the formation of a 
DISC. However, TRADD can also recruit 'Receptor Interacting Protein' (RIP) that 
leads to the activation of NF-kB which protects the cell from apoptosis (Wang et al., 
1998a). TNF Receptor Associated Factor 2 (TRAF2) can also bind to TNFR1 and 
activate the c-Jun N-terminal kinase (INK). Active INK induces apoptosis indirectly by 
activating downstream caspases leading to apoptotic cell death (Liu et al., 1996b) (see 
Fig. 1.4). 
Death signaling via TRAILI Apo-2L 
TNF-Related Apoptosis-Inducing Ligand (TRAIL/Apo2L), was identified as the ligand 
that shares the most similarity to FasL (Wiley et al., 1995). TRAIL, which is 
constitutively expressed in many human tissues, induces apoptosis in a number of tumor 
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cell lines and surprisingly is relatively non-toxic to normal cells (Lacour et al., 2003; 
Uno et al., 2002). The reason behind the selective toxicity may be due to the existence 
of a family of four membrane-bound TRAIL receptors (TRAIL-R1-R4). All of the 
receptors can bind TRAIL, yet they differ in their ability to transduce the death signal 
(Griffith et al., 1999; LeBlanc et al., 2003). Recently, this hypothesis has been 
challenged based on poor correlations between TRAIL receptor expression and TRAIL 
sensitivity. This suggested that other factors, such as TRAIL-induced NP-KB activation 
(Eid et al., 2002; Rivera-Walsh et al., 2001) or death inhibitors including c-FLIP (see 
section I GI) (Kreuz et al., 2001; Siegmund et al., 2002), are involved in determining 
differential sensitivity to TRAIL (MacFarlane et al., 2003). 
Among the initiator caspases processed at the DISC, caspase-8 activation in particular 
has been extensively studied (Boatright et al., 2003; Krueger et al., 2001a; Krueger et 
al., 2001b; Medema et al., 1997; Muzio et al., 1997; Srinivasula et al., 1996). Results 
showed that, caspase-8 can only be cleaved when bound to the DISC (see above). 
Binding of caspase-8 to the DISC induces conformational changes in the enzyme 
(Medema et al., 1997) whereby the intrinsic enzymatic activity of the zymogen is 
sufficient to allow the reciprocal activation of recruited procaspase molecules (Boatright 
et al., 2003; Muzio et al., 1997). Most likely caspase-2 and caspase-lO are activated at 
the DISC by a similar mechanism to the one described above. (Ducoroy et al., 2003; 
Fernandes-Alnemri et al., 1996; Sprick et al., 2002). 
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Fig 1.4: Schematic representation of Receptor mediated pathway, trimerization 
of FAS and TNFR receptors initiates recruitment of various adaptor proteins 
(see text) through homophilic DD interactions leading to the binding of pro-
caspase-8 (via its DED domain) and its transcatalytic activation 
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I Fib. Mitochondrial-stress induced signaling pathway 
It is now well established that mitochondria undergo major changes in membrane 
integrity before manifestation of the classical morphological apoptotic signs. The first 
report on the involvement of mitochondria in programmed cell death came from a study 
showing that the induction of apoptosis in cell free extracts requires cytochrome c and 
dATP (Liu et al., 1996a). During apoptosis the mitochondrial membrane is 
permeabilised and cytochrome c is released to the cytoplasm. In the cytosol, 
cytochrome c interacts with Apoptosis activating factor-1 (Apaf- 1), dATP and 
procaspase-9 to form a complex called the apoptosome (Cain et al., 2000; Cecconi et al., 
1998). Cytochrome c is required for Apaf-1 activation since cytochrome c null mice fail 
to activate the stress induced caspase cascade (Li et al., 2000). 
Apoptosome formation and Caspase-9 activation 
Similar to caspase-8, caspase-9 activation was studied in detail. Caspase-9 exists in vivo 
primarily as an inactive monomer and its activation requires dimer formation (Renatus et 
al., 2001). Although caspase 9 in solution is predominantly a monomer, the high protein 
concentrations used for crystal growth compels its dimerization. Hence, the crystal 
structure of caspase-9 contain four catalytic domains, consisting of the two caspase 
dimers. What is interesting about caspase-9 is that unlike other caspases, proteolysis is 
not sufficient or even unnecessary for its activation (Rodriguez and Lazebnik, 1999; 
Stennicke et al., 1999). As stated above, dimer formation is a crucial step in its 
activation, yet the dimerization cannot occur with the in vivo concentration of 
procaspase-9 (20 nM) (Stennicke et al., 1999). This obstacle is overcome by the 
formation of the apoptosorne, where procaspase-9 molecules are recruited and stabilized 
on Apaf- 1 oligomers by homophilic interaction between Caspase Activated Recruitment 
Domains (CARDs) (Cain et al., 2002; Cain et al., 2000). 
To clarify, the CARD of caspase-9 can interact with other CARDs found in various 
apoptotic proteins, most importantly, Apaf-1 (Bratton et al., 2000). The structure of 
Apaf- 1 revealed that it is composed of three domains, an N-terminal caspase recruitment 
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domain (CARD), a central CED-4 homology domain, and 12-13 repeats of WD-402 in 
the C-terminal half (Qin et al., 1999; Zou et al., 1997; Zou et al., 1999). The WD-40 
repeats are thought to interact with cytochrome c whereas the CED-4 homology domain 
mediates the oligomerization of Apaf-1 in the presence of dATP. Following the release 
of caspase-9, in the cytoplasm Apaf- 1 binds cytochrome c and alters the conformation of 
the WD-40 repeat region. This, in the presence of dATP, enables Apaf- 1 oligomerization 
via a mutual interaction of the CED-4-like regions. In addition, the association with 
cytochrome c and dATP induces a conformation change in Apaf- 1, enabling it to recruit 
caspase-9. The oligomerized Apaf-1 recruits procaspase-9 via a homophilic 
CARD/CARD interaction (Hu et al., 1998; Hu et al., 1999; Lauber et al., 2001; Qin et 
al., 1999). In the stabilized apoptosome, caspase-9 can form dimer molecules and dimer 
formation may activate the caspase. Theses dimers are active in an unprocessed form, 
and each heterotetramer has a single active site. Thus, in a unique manner, the 
activation of caspase-9 zymogen is reliant on cytosolic factors where the apoptosome is 
an essential regulatory subunit (Chen et al., 2002). 
The final outcome of either 'stress-induced' or 'receptor mediated apoptosis' is 
ultimately cell death, since both pathways lead to caspase activation bringing the cell to 
the final execution phase (Green and Amarante-Mendes, 1998). The two pathways are 
not totally independent and it has been well established that pathway 'cross talk' exists. 
For example, it is well established that caspase-8 is indirectly involved in cytochrome c 
release by cleaving the pro-apoptotic Bc12-family members such as Bid (See section I H) 
(Gross et al., 1999; Luo et al., 1998; Sang et al., 2003). Bid, is cleaved by caspase-8 
after Fas/TNF-R1 engagement (Moreau et al., 2003; Nechushtan et al., 2001). 
Specifically, in type II cells3 , cell death triggered by Fas ligation must proceed through a 
mitochondrial amplification step in order to cause cell death (Scaffidi et al., 1999). 
2 Loosely conserved set of sequences found in many regulatory proteins, such as beta-subunits of heterotrimeric G 
proteins. 
Flowing the initiation of the apoptotic process via the death receptor pathway, the amount of active caspase-8 
generated at the DISC determines whether cells are of type I or type II. In type I cells, induction of apoptosis is 
accompanied by activation of large amounts of caspase-8 at the DISC, whereas in type II cells DISC formation and 
caspase-8 activation are strongly reduced. The small amounts of activated caspase-8 is responsible for cleaving a 
molecule called Bid (see section I 1-12) which induces cytochrome c release from the mitochondria and generate the 
amplification loop for the death receptor induced apoptosis via the activation of caspase-9. 
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Fig 1.5:: Schematic representation of Stress induced pathway, Mitochondrial 
stress (via caspase-2 and BcI-2, see txt section I H for more details) induce the 
release of cytochrome c into the cytoplasm. Cytochrome c along with dATP 
induces conformational changes in Apaf-1 allowing its oligomerization into a 
complex capable of recruiting and activating caspase-9 and other effector 
caspases. 
22 
Genetic analysis of caspase 6 and 7 function in vertebrate DT40 cell line 
Upon activation, initiator caspases proteolytically cleave effector caspases through a 
regulated sequence of reactions that separate the large and small subunit, and then detach 
the short prodomain (Earnshaw et al., 1999; Earnshaw et al., 2000). Before proceeding 
any further it is important to point out that, other than caspases themselves, the only 
mammalian protease known to cleave and activate caspases is granzyme B which has 
also been implicated in apoptosis (Galvin et al., 1999; Zapata et al., 1998). (Fig. 1.5). 
Apoptosis Initiating Factor (AIF), Smac/Diablo,OmiJHtrA2 and EndonucleaseG 
(EndoG) 
Cytochrome c is not the only apoptotic factor released from the mitochondria during 
apoptosis. Recently four proteins, normally located in mitochondria, with a function in 
apoptotic execution were identified. They include, AIF (Daugas et al., 2000; Lorenzo et 
al., 1999), EndoG (Li et al., 2001; Parrish et al., 2001), Smac/Diablo (Wu et al., 2000) 
and Omi/HtrA2 (see section I G3 (Hegde et al., 2002; van Loo et al., 2002). 
Smac/Diablo and Omi/HtrA2 will be described in Section I G3. 
AIF was identified as a novel mitochondrial protein restricted to the intermembrane 
space responsible for chromatin condensation and DNA fragmentation in apoptotic 
nuclei (Susin et al., 1999). Crystal structure analysis indicated that AIF possesses an 
oxidoreductase enzyme activity and contains a DNA binding site in a groove on the 
surface of the molecule (Mate et al., 2002; Ye et al., 2002). Under normal conditions, 
AIF is a flavoprotein that acts as an electron acceptor/donor with oxidoreductase 
activity. However, in response to apoptotic stimuli in certain cell types, AIF is released 
from the mitochondria and translocates to the nucleus, where it binds DNA and triggers 
caspase-independent cell death (Susin et al., 1999; Ye et al., 2002). AIF apoptotic 
function is under the regulation of the Bcl-2 family of proteins (see section I H). Bcl-XL 
blocks both AIF and cytochrorne c release from mitochondria. Analogous to 
cytochrome c, AIF-mediated cell death is independent of its redox function (Mate et al., 
2002; Miramar et al., 2001). The exact mechanism of AIF function is still not of 
completely understood. Investigation of the pro-apoptotic function of AIF suggests that 
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it is most likely to be mediated via its DNA binding activity (Wang et al., 2002; Zhang 
et al., 2002). 
EndoG, translated in the cytosol, and subsequently imported into the mitochondria, was 
identified as a nuclease that can induce DNA degradation in both worms and mammals 
after apoptosis induction (Li et al., 2001; Parrish et al., 2001). The release of EndoG 
from apoptotic mitochondria occurs at comparable rate to that of cytochrome c. When 
released EndoG is able to induce nucleosomal DNA fragmentation. EndoG activity is 
independent of caspase activation (van Loo et al., 2002). However, EndoG activity is 
not redundant with CAD in all cell types since in chicken B lymphocytes deficient for 
CAD, EndoG is unable to cleave the nuclear DNA'(Samejima et al., 2001). 
I G. Regulation of caspase activation 
I Gi. Death receptor pathway regulation 
Upstream caspase-8 activation is regulated at the receptor level through a specific group 
of inhibitors collectively named FLIPs (FLICE Inhibitor Protein) (Irrnler et al., 1997; 
Keppler et al., 1999; Thome et al., 1997). FLIPs are Death Effector Domain (DED) 
containing proteins. The first to be identified were viral FLIPs (v-FLIP) (Hu et al., 
1997a; Thome et al., 1997). Characterization of v-FLIPs showed that they were capable 
of inhibiting the induction of apoptosis by several death receptors (CD95, TNF-R1, 
DR3, and DR4), suggesting that these receptors use similar signaling pathways 
(Grundhoff and Ganem, 2001; Meinl et al., 1998; Renne et al., 2001). Soon after, many 
research groups discovered a human homologue of v-FLIPs, cellular-FLIP (c-FLIP4 ) 
(Goltsev et al., 1997; Hu et al., 1997b; Inohara et al., 1998; Shu et al., 1997). Two splice 
variants of c-FLIP were described, c-FLIPs and c-FLIPL (Scaffidi et al., 1999). c-FLIPS  
is more related to its viral counterparts and is composed of two DEDs and a short C-
terminal extension. c-FLIPL resembles caspase-8 by containing tandem DEDs and a 
caspase-like domain. However the latter lacks amino acid residues that are critical for 
c-FLIP has many names including FLAME-11, 1-FLICE, Casper, CASH, MRIT, CLARP, and usurpin. 
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caspase activity (Irmier et al., 1997; Scaffidi et al., 1999). The exact mechanism of c-
FLIP action is still under investigation. Elaborate work from various studies strongly 
suggests that c-FLIPs are potential competitive inhibitors of caspase-8, preventing its 
activation at the DISC (Aron et al., 2003; Lens et al., 2002; Micheau et al., 2002; Rasper 
et al., 1998). However, c-FLIP does not abolish the recruitment of caspase-8. On the 
contrary, in the presence of both FLIPs and C-FLIPL caspase-8 still associates with the 
DISC. Hence, the mode of action of c-FLIPs is not inhibition of caspase recruitment but 
rather an inhibition of caspase activation (Krueger et al., 2001b; Xiao et al., 2002). 
Indeed, FLIPs and FLIPL are reported to form a caspase-8/ FLIP heterodimers (Krueger 
et al., 2001b; Perez and White, 2003). Interestingly, FLIPL forms a caspase-
8/heterodimer in which caspase-8 along with FLIPL are partially processed in the 
presence of high concentrations of FLIPL (Krueger et al., 2001b; Scaffidi et al., 1999). 
The cleavage of both protein might be the basis of caspase inhibition. It has been 
suggested that in the caspase-8/ FLIPL complex, the initial step of caspase-8 cleavage 
proceeds autocatalytically. However this processed caspase domain formed could be 
inactive, consequently the second transcatalytic step of caspase-8 activation can not take 
place (Krueger et al., 2001a; Krueger et al., 2001b). 
In addition to inhibiting caspase-8 activation, FLIPs can transmit a signaling cascade 
that promotes cell survival. Through the Fas signaling pathway, FLIPL recruits RIP, 
TRAF1, and TRAF2 to the DISC, consequently activating NF-KB and ERK signaling 
cascades and regulating not only cell survival but cell proliferation and differentiation 
(Bortul et al., 2003; Chaudhary et al., 2000; Kataoka et al., 2000; Liu et al., 2002). 
I G2. Regulation of caspase activation by Inhibitor of Apoptosis Proteins 
(lAPs) 
TAP genes were first discovered in the genomes of viruses. By expressing their viral TAP 
(v-lAP), viruses have evolved mechanisms that block the host cells from destroying 
themselves before viral production has been completed (Deveraux et al., 1999). 
Recently, endogenous mammalian inhibitors homologous to v-TAP have been identified 
(Deveraux et al., 1999; Tamm et al., 1998). To date seven human members of this 
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family have been characterized (XIAP, c-lAP-1, c-IAP-2, NIAP, BRUCE and ML-IAP), 
three of which are involved in caspase inhibition (Holcik et al., 2000; Holcik et al., 
2001; Salvesen et al., 2002). Specifically, human c-lAP-i and c-IAP-2 have been shown 
to inactivate effector caspases such as active caspase-3, and —7 and XIAP is shown to 
inhibit, in addition to caspase-3 and -7, the upstream caspase-9 (Huang et al., 2001). To 
date, none of the lAPs seem to have any effect on the upstream initiator caspase-8 
(Devereaux et al., 1997). 
lAPs are a family of proteins are characterized by one or more characteristic BIR 
Baculovirus lAP Repeat (BIR) domains, Zn fingers that promote protein-protein 
interaction. In addition to the BIR domain, some family members contain CARD and/or 
RING domains (see Table 1.3 and Fig. 1.6). c-lAP 1, cIAP2, and XIAP have three BIRs 
near the N-terminus of the molecule and a RING finger at the C-terminus. Through 
their BIR domains, lAPs bind and inhibit active caspases. In addition to binding and 
inhibiting caspases, lAPs have multiple biological activities that include regulating cell 
cycle progression, and modulating receptor-mediated signal transduction (Chai et al., 
2001; Huang et al., 2001; Riedl et al., 2001; Roy et al., 1997; Sun et al., 1999; Sun et al., 
2000) (Table 1.3). 













c-lAP 1 and 3 1 1 caspase-3 
c-IAP2  caspase-7 
survivin 1 0 0 caspase-3? 
caspase-7? 




Genetic analysis of caspase-6 and 7 function in vertebrate DT40 cell hue 
Figure 1.6: Inhibitors of apoptosis (lAP) 
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Fig 1.6: Schematic representation of mammalian lAP. 
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The structural basis of caspase-3 and —7 inactivation has been extensively studied and 
seems to function through a similar mechanism. The linker region between the BIR1 
and BIR2 domains is responsible for caspase binding (in their active sites) and 
inactivation (Chai et al., 2001; Riedi et al., 2001). The BIR1/BIR2 linker segment is 
involved in competitive inhibition of both caspase-3 and —7. However, the BIR2 is 
responsible for non competitive inhibition of caspase-7 (Suzuki et al., 2001). The nature 
of inhibition by clAP- 1 and 2 is less understood. On the other hand, sequence alignment 
among TAPs suggests that the mode of binding and inactivation of caspase-3 and —7 is 
conserved (Chai et al., 2001). 
The mechanism of effector caspase-3 and —7 inhibition by XIAP differs from that of 
initiator caspase-9 (Huang et al., 2001). Caspase-9 can only be effectively inhibited by 
XIAP (Deveraux et al., 1999; Suzuki et al., 2001). The BIR3-RING fragment, but not 
the BIR1-BIR2 fragment of XIAP, binds and inhibits caspase-9. It has been recently 
shown that the surface of caspase-9 that interacts with BIR3 also mediates its 
homodimerization. As stated previously, dimerization is an essential step in caspase-9 
activation and monomeric caspase-9 is catalytically inactive. It was shown that XIAP 
sequesters caspase-9 in a monomeric state and ensures that it remains in a catalytically 
inactive state (Shiozaki et al., 2003). 
I G3. Indirect caspase activation via Smacl DIABLO and Omi/HtrA2 
Second Mitochondria-derived Activator of Caspases (Smac/DIABLO) and Omi/HtrA2 
are two mitochondrial proteins that are proteolytically processed and released into the 
cytosol during apoptosis (Du et al., 2000; Martins, 2002). In the cytosol, processed 
Smac/DIABLO and Omi/HtrA2 bind and inhibit a variety of TAPs (Du et al., 2000; 
Srinivasula et al., 2001). Specifically, Smac/DIABLO and Omi/HtrA2 recognize and 
bind to the surface groove on BIR3 of XIAP, competing with caspase-9 for the same 
binding site (Wu et al., 2000). In addition, Smac can also bind to the linker peptide 
between the BIR1 and BIR2 domains, sterically inhibiting caspase-3 and caspase-7 
binding (Huang et al., 2001). Since Smac/DIABLO and Omi/HtrA2 release can trigger 
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the apoptotic cascade, these proteins are kept under tight control to prevent any 
unnecessary or unwanted cell death. Smac/DIABLO and Omi/HtrA2 release is 
regulated by the Bcl-2 family of proteins (see Section I H). In addition, the degradation 
of Smac/DIABLO is also effected by its binding to TAPs (Springs et al., 2002; Wu et al., 
2000). The RING domain of XIAP possesses ubiquitin-protein ligase activity and XIAP 
binds tightly to mature Smac. Further investigations revealed that XIAP functions as a 
ubiquitin-protein ligase (E3) in the ubiquitination of Smac (MacFarlane et al., 2002). 
Whether these two proteins have additional roles in the regulation of apoptosis is still 
under investigation. Recently, it was suggested that Omi/HtrA2, similar to AIF, can 
induce apoptosis in human cells in a caspase-independent manner through its protease 
activity (Hegde et al., 2002). 
I H. Control of apoptosis by the BcI-2 family 
The first report on Bcl-2 dates back to 1985 by virtue of its involvement in a 
chromosome translocation associated with follicular lymphoma (Tsujimoto et al., 
1985). In addition to lymphomas, increased expression of Bcl-2 was also observed in 
several other tumors, including prostate, breast, lung and colorectal cancers (Reed, 
1997). Subsequent studies indicated that Bcl-2 (and other related famility members 
(see below)) not only contribute to tumour progression, but may also confer tumor-
resistance to apoptosis induced by conventional anti-cancer treatments (Naik et al., 
1996). At least 30 proteins belonging to the Bcl-2 family have been identified to date. 
They can be divided into two subgroups, antiapoptotic and proapoptotic. Pro and 
antiapoptotic members can dimerize in order to control each other's function. The 
characteristic variable numbers of Bel-2 Homology (BH) regions found in both 
subgroups (BH1-BH4) determine their capacity to interact with each other or with 
other unrelated proteins (Oltvai et al., 1993) (Fig 1.7). The BH3 domain is thought to 
be crucial for pro-apoptotic interactions since proteins where the only Bcl-2 related 
sequence is the BH3 prodomain are all pro-apoptotic (Bouillet et al., 2002; Chao et 
al., 1998; Fitch et al., 2000; Kawatani and Imoto, 2003; Zong et al., 2001). 
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Figure 1.7 BcI-2 family 
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Fig 1.7: Schematic representation of the three Bcl-2-related proteins family. 
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IH1. Bax and Bak 
Structural similarity of some of the Bcl-2 family proteins to diphteria toxins and 
subsequent studies showing that they can form channels in artificial membranes suggests 
that they regulate apoptosis by influencing ion or protein transport (Minn et al., 1995; 
Muchmore et al., 1996; Schendel et al., 1997). Bak resides on the outer mitochondrial 
membrane oriented toward the cytosol, while Bax is normally located in the cytosol 
(Adams and Cory, 1998; Hausmann et al., 2000; Jia et al., 1999; Suzuki et al., 2001). 
When stimulated, Bax translocates to the mitochondria where it undergoes a 
conformational change, exposing the N-terminus (Desagher and Martinou, 2000). This 
conformational change is thought to allow oligomerization and insertion into the outer 
mitochondrial membrane. Once located in the outer membrane, Bax and/or Bak can 
oligomerize forming channels that are large enough to allow cytochrome c to pass 
through (Godlewski et al., 2001; Ikemoto et al., 2000; Yi et al., 2003; Zhao et al., 2001). 
Interestingly, studies showed that individual Bak or Bax loss has no drastic effect on 
apoptotic execution. On the other hand, inactivation of both proteins has dramatic 
effects. Cells lacking both Bax and Bak are resistant to mitochondrial and endoplasmic 
reticulum stress-induced apoptosis and are completely resistant to tBid-induced 
cytochrome c release and apoptosis (see below) (Cheng et al., 2001; Lindsten et al., 
2000; Wei et al., 2001). 
I H2. BH3-only proteins 
In C. elegans all programmed cell death is orchestrated by one BH3-only protein, EGL-1 
(Conradt and Horvitz, 1998; del Peso et al., 1998). Higher organisms possess multiple 
BH-3 only proteins including Bid, Bim, Bad, Bik, Bmf, Hrk, Bnip3, Nix, Noxa and 
Puma (Cheng et al., 2001; Marani et al., 2002; Moreau et al., 2003; Zong et al., 2001). 
The mode of 13143-only protein function is by insertion of their BH-3 domain into a 
groove of other pro- and anti-apoptotic Bcl-2 members. Activation of BH-3 proteins 
results in rapid cell death, therefore these proteins are keep under tight restraint. For 
example, some mammalian BH3 -only proteins, such as Noxa and Puma, are regulated at 
the transcriptional level (Han et al., 2001; Nakano and Vousden, 2001; Yu et al., 2001) 
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whilst others are regulated post-transcriptionally. For example, Bim and Bid, which are 
sequestered to microtubules or the actin cytoskeleton (Puthalakath et al., 1999; 
Puthalakath and Strasser, 2002; Puthalakath et al., 2001). 
Among the B113-only proteins, Bid was extensively studied and found to be 
exceptionally important in Type II cells (see Section I Fib). Activated caspase-8 cleaves 
the inactive form of Bid into two parts. The truncated Bid, tBid (15 KDa) translocates 
to the mitochondria, (Grinberg et al., 2002; Kim et al., 2000b; Li et al., 1998; Lutter et 
al., 2001; Yi et al., 2003). There, tBid binds Bax, ion channels are formed and 
cytochrome c is released (Brenner et al., 2000; Madesh and Hajnoczky, 2001; Vieira et 
al., 2002; Me et al., 1998). 
BH3-only proteins seem to exert their effects in a tissue-specific manner as suggested by 
mice knockout studies. Bid-deficient mice appear normal with the single observation 
that their hepatocytes are resistant to Fas-induced cell death (Wang et al., 1998). Bim 
knockout mice studies showed that it is required for haematopoietic cell homeostasis and 
prevention of autoimmune diseases as well as neuronal apoptosis (Bouillet et al., 1999; 
Bouillet et al., 2002; Putcha et al., 2002). Interestingly, it seems that the balance between 
the pro-survival and pro-apoptotic proteins dictates the fate of the cell. In Bc1-2 mice 
the removal of a single Bim allele can restore almost all the physiological effects 
associated with Bcl-2 loss (Bouillet et al., 2002). 
Without a doubt, the extensively studied pathways of apoptosis are far from being 
fully mapped. It is one widely accepted view that Bcl-2 family members are the 
upstream effectors in the mitochondrial induced apoptosis and that mitochondrially 
released proteins, rather than caspases, are the active players in cell dismantling. In 
that context, caspases were thought that to be just amplifiers and Bcl-2 members key 
effectors. However, this belief was challenged recently by the finding that the down-
regulation of caspase-2 by siRNA blocks apoptosis induced by DNA damaging 
agents, yet the loss of caspase-2 function had no effect on receptor-induced apoptosis 
(Lassus et al., 2002). Ironically, this finding implies that the two modes of cell death 
might operate through the same mechanism where caspases are the apical players. 
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11. Endoplasmic reticulum (ER), golgi and lyzosome specific 
cell death 
Although most intracellular membranes are permeablised during apoptosis, the main 
focus in organelle-specific apoptosis has always concentrated on the role of 
mitochondria. However, other organelles such as the ER, Golgi apparatus and lysosomes 
also play an a role in cell death (Chen et al., 2002; Hacki et al., 2000; O'Reilly et al., 
2002; Scorrano et al., 2003; Trapani et al., 1998; Zang et al., 2001). 
I 11.The role of the ER in apoptosis 
The most established role of the ER is the post-translational processing of newly 
synthesized peptides from ribosomes, as well as synthesis and metabolism of lipids. 
High levels of sustained ER stress induced by interference with protein secretion can 
lead to apoptosis. (Zinszner et al., 1998). Specifically, caspase-12 is an ER-associated 
cell death effector that is activated by proteolytic processing during ER stress and 
mobilization of Ca stores (Mandic et al., 2003; Nakagawa et al., 2000; Yuan and 
Yankner, 2000). In addition, caspase-12 knockout mouse studies showed that the kidney 
and neurons of caspase-12' mice are resistant to ER-stress, suggesting that caspase-12 
may mediate an ER-specific apoptosis pathway (Nakagawa et al., 2000). 
112. The role of the Golgi apparatus and lysosomes in apoptosis 
The Golgi apparatus is the major site for sorting and modifications of proteins and lipids. 
The main function of lysosomes is degrading various macromolecules. However, both 
organelles are also associated with apoptotic functions. Several apoptosis-inducing 
factors have been associated with the Golgi apparatus including. These include caspase-
2, TNFR-1, TRAIL-RI and TRAIL-R2 (Bennett et al., 1998; Mancini et al., 1998; Wang 
et al., 2003; Zhang et al., 2000). The role of lysosomes in apoptosis is linked to the 
activation and cytosolic translocation of cathepsins (Madge et al., 2003; Zang et al., 
2001). Specifically, the release of cathepsin B and D release is associated with 
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cytocbrome c activation (Guicciardi et al., 2000; Katz et al., 2001; Nakanishi et al., 
2001; Roberg and 011inger, 1998) yet Bid cleavage and activation of pro-caspase-9 
following lysosomal photodamage seems to be independent of cathepsins (Reiners et al., 
2002). To date, the exact contributions of the Golgi apparatus and lysosomes to 
apoptosis are still under investigation. 
I J. Methods employed to study caspase function 
The highly important role of caspases in the apoptotic process was documented by 
several findings and using different methodologies, Including: 
> Overexpression of caspases 
Using synthetic or natural inhibitors of caspases 
> Using the techniques of protein chemistry, enzymology, crystallography, and 
recombinant DNA methodologies 
> Using knock-out animal models to study the individual and specific function of 
caspases 
Using RNA interference 
Among these, it is important to stress the valuable role played by gene knockouts in the 
elucidation of specific caspase function. The primary structure of caspases are very 
similar and conclusions drawn from using specific inhibitors are not completely reliable. 
Therefore, targeted gene disruption has been widely used to determine the individual 
functions of caspase genes in mice (Table 1.2). These studies have identified differential 
involvement for caspases -1, -2, -3, -8, -9, -11 and -12 in development, homeostasis and 
disease (Nakagawa et al., 2000; Zheng et al., 1999). However, this powerful approach is 
less useful when the gene of interest is essential for early embryonic development. 
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I K. The advantages of the DT40 system 
Targeted gene disruption is a very powerful approach to study gene function. 
However, it is limited by low frequency of homologous recombination in most cells. 
DT40, the avian virus-induced bursal lymphoma cell line provides an alternative to 
this problem. These cells retain the ability to diversify their rearranged IgL gene 
during in vitro passages, and this apparently leads to a high rate of homologous 
recombination rate (Kim et al., 1990). 
Similar to avian bursal B cells (Reynaud et al., 1987; Thompson et al., 1987), DT40 
cells continue to diversify their immunoglobulin (Ig) light chain locus by gene 
conversion with pseudogenes serving as donors. It has been demonstrated that DT40 
cells' light chain diversification occurs by gene conversion in a comparable way to 
cells derived from the bursal B cells. Transfection of DNA constructs into DT40 
chicken cells has proven to be highly successful, with targeting efficiencies reaching 
up to 90% (Dieken et al., 1996). Moreover, DT40 cells show an increased ratio of 
targeted to random integration after transfection (Buerstedde and Takeda, 1991). In 
addition to the gene targeting benefit, DT40 cells possess further advantageous 
characteristics. Cells have an invariant karyotype and phenotype and a doubling time 
of 8-10 hours at 39 T. Due to the very high cloning efficiency, isolation of stably 
transfected cells and subcloning of DT40 cells is easily done. Furthermore, a new 
chicken EST database is available at the following web sites: 
htpp://genetica.hpi.uni.hamburg.de/dt4O.html 	(B uerstedde et al., 2002) 
http://www.chicken.umist.ac.uk (Sonoda et al., 2001b). Therefore, the DT40 cell line 
represents a powerful system for generation of knockout cell lines. DT40 cells can be 
further modified, using tetracycline-responsive promoters allowing the expression of 
wild type cDNAs. This can be of great importance when the studied gene is essential 
for cell survival. The cell can be rescued by transfection of the wild type eDNA under 
the control of the tet-operator system (Gossen and Bujard, 1992). Using this system, 
the gene can be turned on or off by removal or addition of tetracycline (Lahti, 1999). 
Given the availability of multiple selectable markers and vectors in which the markers 
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multiple selectable markers and vectors in which the markers are flanked by loxP 
sites, DT40 cells offer another great advantage, namely the possibility to perform 
multiple gene knockouts. Use of multiple knockouts can lead to the exact elucidation 
of signal pathways resulting from the loss of genes involved in one cellular process, 
such as apoptosis. More than 60 genes have been targeted to date in DT40 cells. These 
include, the cell cycle regulator cyclin Dl (Lahti et al., 1997), the DNA repair 
proteins including RAD5 1 (Sonoda et al., 1998) and RAD52 (Yamaguchi-Iwai et al., 
1998), centromere component CENP-C (Fukagawa and Brown, 1997), Sccl (Sonoda 
et al., 2001a), the cohesin subunit SCII (Hudson et al., 2003, University of Edinburgh, 
personal communication), the chromosomal passenger protein survivin (Carvalho, 
University of Edinburgh, personal communication) as well as proteins involved in the 
apoptotic process such as CAD (Samejima et al., 2001) and MEKK1 (Kwan et al., 
2001). In each case, stable deficient cell lines were used to characterize the phenotype 
and elucidate the role of the gene in question. 
I L. Purpose of this study 
Many previous elaborate studies have been conducted to unravel the mechanisms and 
cell signaling pathways that govern caspase activation as well as to understand the 
specific enzyme function and mode of activation in apoptotic execution. Yet, the 
activation and individual roles of particular caspases are not completely understood. 
Three caspases are classified as effector enzymes, namely, caspase-3, -6 and —7. 
Caspase-3 has long been the focus of many investigators, whereas the specific roles of 
caspase-6 and caspase-7 remain to be determined. In this study, a gene knockout 
approach in the DT40 cell line was used to elucidate caspase-6 and caspase-7 function 
in apoptosis. The aim of this thesis is to seek a deeper understanding for specific 
caspase-6 and caspase-7 functions. 
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Chapter II: Material and Methods 
II A. Materials 
Analytical and reagent grade chemicals were purchased from Amersham-Pharmacia, 
BDH, Bio-Rad, Boehringer Manheim and Promega. Hybond, Hybond N+ and Hybond 
C membranes were obtained from Amersham-Pharmacia. Radioactive isotopes were 
supplied by Amersham and oligodeoxynucleotides primers were supplied by Oswell and 
Sigma-Genosys. 
Restriction enzymes were purchased from New England Biolabs (NEB) and Roche. The 
Kienow Fragment was obtained from Amersham-Pharmacia. T4 DNA ligase and T4 
DNA polymerase were obtained from NEB. Taq polymerase was obtained from Roche 
and Takara. Pfu polymerase was purchased from Stratagene. Purchased kits used were 
Qiagen Mini, Midi and Maxi Kit for plasmid DNA preparation. 
II B. Tissue culture techniques 
11 131. Cell culture 
II Bia. DT40 cells 
DT40 cells (Avian Leukosis Viral- induced bursal lymphoma cell line) were grown in 
suspension in RPMI medium supplemented with 10% foetal bovine serum, 1% chicken 
serum and Penicillin (100 U/ml)/ Streptomycin (100 UIml) (GibcoBRL) at 37°C or 
39°C. 
II Bib. Hela cells 
HeLa cells (Henrietta Lacks cervical carcinoma cell line) were grown attached in RPMI 
medium supplemented with 10% foetal bovine serum and Penicillin (100 U/ml)/ 
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Streptomycin (100 U/mi) (GibcoBRL) at 37°C. The cells were harvested by addition of 
1% trypsin and incubation at 37°C for the desired time. 
II Bic. Jurkat cells 
Jurkat cells (human leukemia T cell line) were grown in suspension in RPMI medium 
supplemented with 5% foetal bovine serum and Penicillin (100 U/ml)/Streptomycin (100 
U/mi) (GibcoBRL) at 37°C. 
II B2. Stable transfection of DT40 cells 
1x107  cells were centrifuged (3000 x g for 5 min at room temperature) and washed once 
with 25 ml ice-cold Optimem (Gibco-BRL). The cells were centrifuged again, 
resuspended in 0.5 ml ice-cold Optimem and transferred to Gene Pulser cuvettes (Bio-
Rad 0.4 cm electrode gap). 20-25 .tg of linearized vector was added to the cells and 
mixed by pipetting, then samples were left on ice for 10 minutes. Transfection was done 
by electroporation (300 V 950 tF) with the Gene Pulser apparatus (Bio-Rad). After 
electroporation, the cells were incubated on ice for 10 minutes, then transferred to 10 ml 
of pre-warmed (37'C) RPMI supplemented with 10% foetal bovine serum, 1% chicken 
serum and Penicillin (100 U/mI)! Streptomycin (100 U/ml) (GibcoBRL) and incubated 
at 39°C for at least 24 hours. Cells were expanded to 40 ml of appropriate selective 
media in RPMI (supplemented with 10% foetal bovine serum, 1% chicken serum and 
Penicillin (100 U/mi)! Streptomycin (100 U/mi) (GibcoBRL) and seeded into 96 well 
plates (100 p1 per well) and grown at 39°C. 
II B3. DT40 drug selection 
Transfected cells seeded into 96 well plates were incubated in appropriate drug selective 
medium from 6-10 days depending on the type of drug used. The selection drugs were 
used at the following concentration: 
Blasticidin: 	25 [tg/ml 
1-listidonol: 	1 mg/ml 
Hygromycin B: 2.5 mg/ml 
Neomycin: 	2 mg/ml 
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> Hygromycin B: 2.5 mg/ml 
	
> Neomycin: 	2 mg/ml 
Puromycin: 	0.5 .tg/ml 
Only single colonies were picked into non-selective RPMI media (supplemented with 
10% foetal bovine serum, 1% chicken serum and Penicillin (100U/ml)/ Streptomycin 
(100U/ml) (GibcoBRL) and placed at 39°C. 
11 134. Tetracycline regulated system for gene expression (tTA) 
The tTA (Tetracycline regulated system for gene expression) was developed by Gossen 
and Bujard in 1992 (Gossen and Bujard, 1992). In this system, the tetR (tetracycline 
repressor) system described in E. coli was modified to create a chimeric transcriptional 
activator domain that allows its own expression along with the target gene in cultured 
cells. 
The tTa system was developed by fusing the full-length tetR to the transcriptional 
activation domain of the herpes simplex virus VP- 16. In the absence tetracycline the tTa 
is associated with the tetO DNA sequence causing the recruitment of RNA polymerase, 
hence allowing transcription. However, when tetracycline is added tTA dissociates from 
the tetO. As a consequence, the transcpitional complex is released from the DNA and 
transcription is abrogated. The advantage in using tetracycline as a repressor is its low 
toxicity to mammalian cells and ready absorption across the plasma membrane. The tTa 
2/3/4 plasmids express tetracycline-controlled transactivators containing minimal VP16 
activation domains. These mutated VP16 domains do not bind as efficiently to the target 
thus reducing the relative transient activation to 39% and 14% for tTA 3 and 4 
respectively (Baron et at., 1997). 
Vector construction: The full length gene of interest, caspase-6 in this case, was cloned 
into the PUHD 10-3 vector (Manfred Gossen-unpublished, ZMBH, Heidelberg), 
downstream the EcoRI/XbaI multiple cloning site. The resulting plasmid was digested to 
completion with XbaI and used along with tTA3 and tTA4 (caspase-6) and 
contransfected into DT40 cells by electroporation at a molar ratio of 1/10 respectively. 
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II C. Common molecular biology methods 
II Cl. Restriction enzyme digestion 
II Cia. Complete digestion 
Restriction enzyme digestion was carried out in recommended buffers, at temperatures 
and conditions according to the manufacturer's intructions. On average, a 5-fold excess 
of enzyme was used. For plasmid DNA, digestion was carried out for 2 hours. For phage 
DNA, the incubation was carried out for at least 3 hours. For genomic DNA incubations 
were performed overnight, for 14-16 hours. 
II Cib. Partial digestion 
Partial digestion was performed by serial dilution of the enzyme. The DNA was 
quantified by measuring the OD (optical density) at 260 nm and 280 nm. 10 ig of DNA 
were completely digested by Nod in a final concentration as follows: lx of NotI buffer 
and 15 U of the assayed enzyme in 30 jil total volume. Afterward, the volume was 
increased to 160 xl containing lx of the restriction-enzyme buffer to be tested and 
divided into 5 samples, on ice, as follows: 30 tl, 20 !Ll, 20 p1, 20 .tl, and 10 .tl in the 
first, second, third, fourth and the fifth tube, respectively. 15 U of the enzyme was added 
to the first tube, and mixed by pipeting. Working on ice, 10 jil of the first tube mixture 
was transferred to the second performing serial dilutions. The final amounts of the 
enzyme per reaction tube were 10 u, 3.3 u, 1.1 u, 0.3 u and 0.1 u, against 2 ig of DNA 
in each of the five tubes. The reaction was further incubated for 15 minutes at 37°C and 
immediately transferred to 70°C for 10 minutes or frozen on dry ice in cases where the 
enzyme can readily not be heat inactivated. The reactions were loaded on a 0.6% 
agarose gel containing ethidium bromide (1 .tg/ml) to visualise the DNA, and 
electrophoresed for 3 hours at 100 V. Then, the picture was taken under UV against a 
marker ruler. 
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II C2. Agarose gel electrophoresis 
Agarose gels were run in lx TAE buffer (0.04 M Tris-acetate, pH 7.5, 0.001 M EDTA). 
Gel concentrations ranged from 0.6% to 3% depending on the size of band to be 
resolved. Gels were supplemented with ethidium bromide to a final concentration of 1 
tg/m1. DNA bands were visualised under UV light and photographed with a digital 
camera. 
II C3. Agarose gel blotting on nylon membrane 
The gel was depurinated by soaking it in 0.25 N HC1 for 30 min and rinsed with dH20. 
Then the gel was denatured in 1.5 M NaCl, 0.5 N NaOH for 2 x 15 minutes, rinsed with 
dH20 again, and neutralised for 20 min with 0.5 M Tris-Cl pH 7.5, 1.5 M NaCl, 0.01 M 
EDTA). The gel was transferred to a pre-wet nylon membrane (HybondN, Amersham) 
by upward capillary transfer (Sambrook J. and Russel D.W, 2001). The transfer was 
performed with 10 x SSC (10 x stock: 1.5 M NaCl, 0.15 M sodium citrate, pH adjusted 
to 7.0 with citric acid) overnight; alternatively the gel was transferred using the 
VacuGeneTM Vacuum blotting system (Pharmacia Biotech) for 2 hours. The membrane 
was dried at room temperature and the DNA was UV crosslinked at 1200 J. 
II C4. Purification of DNA from agarose gel 
DNA fragments from digested plasmids or PCR products were separated on agarose 
gels. The fragments were visualised under UV and the band of interest cut out with a 
thin scalpel blade. DNA fragments were purified from the agarose gel using the Qiagen 
gel extraction kit according to the manufacturer's recommendations. 
II C5. DNA sequencing 
Sequencing was performed at the ICMB (Institute of Cell and Molecular Biology, 
University of Edinburgh) sequencing facility using on ABI 3100 sequencing machine. 
200-500 ng of DNA, 3.2 pmole of primers and 4 tl of ABI big dye mix (Applied 
Biosystems) were mixed with water in a final volume of 10 il. 25 Cycle sequencing 
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Biosystems) were mixed with water in a final volume of 10 lii. 25 Cycle sequencing 
reactions (95°C 1, min 50°C 15 sec, 60°C 4 mm) were amplified following 
manufacturer's recommendations. The DNA pellet was then precipitated at room 
temperature for 15 minutes by adding 1 jtl of 3 M of sodium acetate and 25 tl of 100% 
ethanol per reaction. The DNA was then centrifuged at 20,000 x g for 15 minutes, 
washed with 70% ethanol and then re-centrifuged and air dried. Sequences were 
analysed using computer programs, including Editview (ABI Prism, Perkin Elmer), 
Gene Jockey (BioSoft) and Sequencher (Gene Codes Corporation). Plasmid maps were 
constructed using DNA Strider. 
II C6. DNA sequence labeling and membrane hybridization 
II C6a. Oligo nucleotide probe preparation 
20 pmol of DNA oligonucleotide was added to a 20 .i1 total reaction mixture containing 
1 x kinase buffer, 5 p1 of 'y-32P dATP (5000 Ci/mmol) and 10 U of T4 polynucleotide 
kinase. The reaction mixture was incubated at 37°C for 45 minutes. After inhibiting the 
reaction at 65°C for 10 minutes, 80 p1 of TE buffer plus 1 p1 of 1 M EDTA (Nat) were 
added to the mixture, which was then passed through a 10 cm G-25 Sephadex column by 
centrifugation at 1800 x g, for 4 minutes. The purified probe was added to the 
hybridisation buffer (6x SSC, 5x Denhardt's, 0.2% SDS) and incubated overnight at 
30°C. The membrane was washed at 30°C in 3x SSC, 0.2% SDS until the desired signal 
strength remained. 
II M. DNA probe preparation 
DNA sequences to be used as probes were labelled using the Megaprime DNA labelling 
system (Amersham), following the manufacturer's protocol using 1 jig of DNA. After 
labelling, the reaction mixture was passed through an 8 cm G-50 Sephadex column or 
ProbeQuantTM  G-50 Micro columns (Amersham Pharmacia), which were centrifuged at 
1800 x g, for 2 minutes. The purified probe was added to the hybridisation buffer, 
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Church buffer (0.5 M NaPi (Disodium hydrogen orthophosphate dehydrate pH 7.5), 7% 
SDS, 1 mM EDTA) and incubated overnight at 65°C. The membrane was washed at 
65°C in 40 mM NaPi, 2% SDS. 
The radioactive signal on the membrane was revealed using Kodak MS-1 film and 
intensifying screens at —80°C. 
II D. DNA preparation 
II Dl. DNA amplification 
IlDia. PCR 
PCR primers were commercially prepared either at Oswel or Sigma Genosys. The 
following Table 2.1 shows the specific primers sequences designed for particular DNA 
amplifications. 
The PCR reaction was performed under standard conditions as recommended by the 
manufacturers. The conditions used for each enzyme are summarised in Table 2.2. 
Table 2.1: Primers sequence and usage 
J1Inr1dFur. 
KO Eco3F GGGGAATT'CCAACCAGTAATGTGAGATCG 
Use  
3' arm of KO vector 
KO Hind3R GGGAAGCTFGCACAAGAGGAAGTCTGCTC 
KO Bam5R GAAGGATCCCTGCAGTCAACTGCGATATC 5' arm of KO vector 
KO SacII5F GTTCCGCGGCACTGGGTATCAGAGAAGCA 
NP3 TCGAATFCCTCACTGAAGCGTGGATC C-terminal 73 amino acids of 
caspase-7 used for RT-PCR NP5 AGGGGATCCCTG'VI17GATATTCCACA 
NKC73 TCGGATCCCAGAAGTAAAGTTCCTTA Cloning caspase- 7 ORF in 
pEGFPN- I NKC75 CCGAA1TCATGTCAGGAGATCAGCAT 
Probe 3F GAAAGATAAC1TI'GAGAG 3' external probe 
Probe 3R CATATCCACTCGTCATFG 
Probe 5F GTCATGCTGCTCCTGTTC 5' external probe 
Probe 5R AATGTGAGTGTCTCTGCC 
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Table 2.2: PCR conditions 
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' 200 nM 
polymerase 2 min 55 °C-65 °C, 45 sec 
(Roche)  72 °C ,30 sec/kb  
TaKaRa LA 94°C, 30 94°C, 1 min 200 nM 200nM 
Taq) 5 min 55°C-65°C, 
(TaKaRa 72 °C 30 sec/ kb 
Shuzoco, Ltd)  
pfuTurbo 95°C, 35 95°C, 1 min 250 ng 250 nM 
(Stratagene) 5 min 55 °C-65 °C, 1mm 
76 'C , 2 mm/kb  
PCR fragments were analysed by agarose gel electrophoresis. Desired DNA fragments 
were gel purified using a Qiagen gel extraction kit or cleaned up using an UltraClean 
PCR cleanup kit (MoBio). Taq (Roche or Takara) amplified DNA fragments were 
cloned into PEGM-T vector (Promega), Topoll or Topo2. 1 vectors (Invitrogen). For 
pfuTurbo amplified DNA fragments to be used in cloning experiments the primers were 
designed to contain restriction sites specific for cloning in the desired vectors. Except 
when PCR was used as a screening method, amplified PCR fragments were cloned and 
sequenced fully on both the 5' and 3' strands. If the DNA fragment accuracy was not 
crucial or critical for its subsequent experimental use, only one step of sequencing for 
each strand was performed for each strand using the vector specific primers. 
II 02. RT-PCR 
cDNA was synthesised using the SuperScriptTM  First-Strand Synthesis System for RT-
PCR (Invitrogen) following the manufacturer's recommendations. The total or polyA 
mRNA was prepared (as described in section 11 1-12) and the first strand cDNA reaction 
was primed using oligo (dT) primers to hybridise to the 3' polyA tail. 1 tg of total RNA 
or 100 ng of polyA(+) RNA were used per reaction. The cDNA obtained was amplified 
directly by PCR using 2 jil per reaction (which would correspond to 10% of the first 
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strand eDNA obtained). The PCR reaction was performed as described in the previous 
section. 
II D3. Mini scale DNA preparation 
A single colony was picked and placed in 2 ml LB medium (1% tryptone, 0.5% yeast 
extract, 1% NaCl, pH adjusted to 7.0 with 5 N NaOH) containing the appropriate 
antibiotics and left shaking at 37°C for a minimum of 8 hours. Plasmid DNA was then 
isolated and purified using the UltraClean mini plasmid kit (MoBio) according to the 
manufacturer's recommendations. 
II D4. Large scale DNA preparation 
A single colony or 100 Vtl of previously grown bacterial culture were placed in buffle 
flasks containing 50 ml (medium scale) or 100 ml (large-scale) of LB medium plus the 
appropriate antibiotics and left shaking for 14-16 hours at 37°C. Plasmid DNA was 
isolated and purified using a QlAfilter plasmid midi or maxi kit (Qiagen) according to 
the manufacturer's recommendations. The plasmid DNA thus obtained was quantified 
by reading the absorption at 260 and 280 nm and subsequently analysed by gel 
electrophoresis. 
II E. Protein analysis 
II El. Whole cell extract preparation (cultured cells) 
Cell number was determined using a haemocytometer. The desired number of cells was 
taken, centrifuged at 800 x g for 5 min and washed once with lx PBS (137 mM NaCl, 
2.7 mM KC1, 10 mM Na2HPO4, 2 mM KH2PO4). Cells were lysed in sample buffer 
(150 mM Tris:HC1 pH 6.8, 45% sucrose, 6 mM K-EDTA pH 7.4, 9% SDS, 0.03% 
bromophenol blue) and boiled for 5 minutes at 100°C. Extracts were either used directly 
or stored at -20°C. 
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II E2. DT40 cytosolic extract preparation 
Cytosolic extracts were mainly used in in vitro experiments for the induction of 
apoptotic execution. Hence, cytosolic extracts were prepared from untreated and 
apoptotic DT40 cells (Lazebnik et al., 1993). Cells were induced to undergo apoptosis 
either by 10 tM etoposide treatment for 5-6 h or 1 tM staurosporine treatment for 7-8 h. 
Cells were collected, centrifuged at 800 g and washed once in 25 ml PBS and then once 
in 10 ml KPM buffer (50 mM Pipes, pH 7.0, 50 mM KC1, 5 mM EGTA, 2 mM MgCl2, 1 
mM DTT, 50 pM cytochalasin B, PMSF, chymopain, leupeptin, antipain and pepstatin). 
Cells were finally resuspended in 1 ml of KPM buffer transferred to a 1.5 ml eppendorf 
tube and centrifuged at 250 x g. The supernatant was aspirated and the cell pellet was 
frozen in a mixture of dry ice/isopropanol. Cells were lysed by three cycles of 
freeze/thaw, then sonicated and centrifuged at 190,000 x g for 2 h at 4°C. Keeping the 
samples on ice, the clear supernatant was collected, aliquoted and frozen at -80°C. The 
amount of protein was quantified using the Bradford assay (Bio-Rad). 
II E3. SDS —Polyacrylamide gel electrophoresis of protein samples 
Proteins were separated on 1 -D SDS-polyacrylamide gels. The composition of resolving 
gels and the duration of electrophoresis were dependent on the protein size. Table 2.3 
shows the correlation between the concentration of acrylamide and the molecular weigh 
of protein to be separated. Table 2.4 and 2.5 shows the composition of resolving gels 
and stacking gels when preparing 20 ml and 5 ml respectively. 
Proteins were detected either with Coomassie blue or silver staining or transferred to a 
nitrocellulose membrane for immunoblotting experiments. 
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Table 2.3 










Table 2.4: Resolving gel composition 
1.5 M Tris pH 8.8 5 m 
III 
5 5 5 5 5 5 
30% acrylamide/bis 
stock(BioRad) 
5.4 6.7 8.3 8.65 9 10 10.3 
20%SDS 0.1 0.1 0.1 0.1 0.1 0.1 0.1 
1-120 9.4 8.1 6.5 6.15 5.8 4.8 4.5 
10%APS 0.2 0.2 0.2 0.2 1 0.2 
TEMED 0.02 0.02 0.02 0.02 0.02 
0.2 	___F0.2 
0.02 0.02 
Table 2.5: Stacking gel composition 









Gels were run in tank buffer (25 mM Tris, 250 mM g!ycine, 0.1% SDS). The duration of 
the runs depended on the percentage of the gel and the size of the protein to be analyzed. 
In general, Mini gels (8 cm x 5cm) were run at 200 V for 45 min to 1 hour and large gels 
were run for a total of 80 mA to 120 mA for variable lengths of time. 
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II E4. Immunoblotting 
Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose 
membranes was carried out using a Bio-Rad transfer apparatus according to the 
manufacturer's instruction in transfer buffer (48 mM Tris, 39 mM glycine, 20% 
methanol and 0.0375% SDS) at 4°C for 1.5 hours at 250 mA for mini gels and 3 hours at 
400 mA for large gels. After transfer, membranes were washed with PBS, stained with 
PonceauS (Sigma) to visualize the proteins and blocked either with 5% low fat dry milk 
or 3% BSA in PBS. The primary antibody was added in blocking solution and incubated 
for 1-3 hours at room temperature or 16 hours at 4°C depending on the antibody used 
(Table 2.6). Membranes were washed three times for 10 min with blocking solution, 
then the appropriate, horseradish peroxidase-conjugated secondary antibody was applied 
at a dilution according to the manufacturer's recommendations. The signal was revealed 
using ECL solutions (Amersham-Pharmacia). 
Table 2.6: Working dilutions of antibodies usedfor immunoblotting 
Caspase-6 
incubation time 
1:500/ 3 hours RT Ruchaud et al., 2002 
Lamin B  1:500/3 hours RT Zymed laboratories 
(E-3)  
Lamin B2 1:500 / 3 hours RT Zymed laboratories 
(L-5)  
Lamin A 1:1000/3 hours RT Provided by Dr. Reimer 
(Clone 4B4-1 1)  Stick 
Monoclonal anti-tubulin 1:10000/ 1 hour RT Sigma 
(B512) _ 
PARP 1:250 / 4 hours RT Cell Signaling 
(9542) 1 (NewEngland biolabs) 
II E5. Immunofi uorescence analysis 
Cultured cells were adhered to slides either by incubating on polylysine coated slides 
(BDH) for 30 min at 37 or 39°C or by cytospinning 500 p1 at 500 x g for 5 min using the 
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Cytospin3 apparatus (Shandon). Slides were washed twice with PBS, fixed in 4% 
formaldehyde in PBS solution for 5 min at room temperature, stained with DAPI (5 
p.g/ml) and mounted with Vectashield (Vector). Images were captured on a Zeiss 
Axioplan II epifluorescence microscope using a Princeton Instruments Micromax cooled 
CCD camera and processed using IP lab Spectrum software. 
II F. Cloning experiments 
II Fl. Bacterial host strains 
DH5a (Gibco-BRL) and Top 10 (Invitrogen) cells were used for all standard DNA 
cloning. 
II F2. Plasmid vectors 
pBluescript (KS or SK) (Stratagene) for standard cloning 
pGEM-T (Promega), Topo II and Topo 2.1 (Invitrogen) for Taq amplified PCR 
fragments 
> pUHD 10-3 (Manfred Gossen-unpublished, ZMBH, Heidelberg) for tetO-dependent 
expression 
pCDNA3 (Invitrogen) for mammalian expression 
The DNA used in cloning was purified plasmid or phage DNA or a PCR product. 
II F3. Dephosphorylation of the end of a DNA sequence 
Dephosphorylation was performed using calf intestinal alkaline phosphatase (CIP) 
(NEB) in the appropriate restriction buffer. 0.5 U CIPItg of digested DNA were mixed 
and incubated for 1 hour at 37C. The enzyme was then heat inactivated at 70°C for 15 
mm. The DNA was purified using the UltraClean PCR cleanup kit (MoBio) according to 
the manufacturer's recommendations. 
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II R. Blunting the end of a digest DNA fragment 
Overhangs were blunted using T4 DNA polymerase (NEB). 2 U of the enzyme were 
added to the reaction mixture in the presence of lx T4 polymerase buffer and 250 tM 
dNTP. The reaction was incubated for 5 min at 37°C. The enzyme was heat inactivated 
at 70°C for 20 mm. The DNA fragment was then purified using the UltraClean PCR 
cleanup kit (MoBio) according to the manufacturer's recommendations. 
II F5. 	Ligation 
For both 'sticky' and blunt end ligation the reaction was performed in a total volume of 
20 RI at a 3/1 ratio of insert/vector DNA amount in lx NEB ligation buffer, 250 U of 
concentrated T4 DNA ligase (NEB). The tubes were placed into the PCR machine for 6-
12 hours and exposed to a temperature gradient cycling between 16°C and 22°C with a 
rate of 1 min/'C. 
II F6. Transformation of Competent bacteria 
II F6a. Preparation and transformation of chemical competent E. coil 
Preparation: E. coli were grown in 100 ml of LB at 37°C to an 0D600 of 0.5, then 
transferred to ice for 5 minutes. Cells were pelleted by centrifugation at 3300 x g for 15 
minutes and then re-suspended in 40 ml TIbI (30 mM potassium acetate, 100 mM 
RbC12, 10 mM CaC12, 50 mM MnC12, 15% glycerol. pH to 5.8 with dilute acetic acid, 
filter sterilised and stored at 4°C). Thereafter, cells were centrifuged and re-suspended in 
4 ml TiblI (10 mM MOPS, 75 mM CaCl2,  10 mM RbCl,, 15% glycerol. pH to 6.5 with 
KOH, filter sterilised and stored at 4°C) and incubated on ice for 15 minutes. Cells 
distributed into 100 jil aliquots were snap frozen in liquid nitrogen and stored at -80°C. 
Transformation: Competent bacteria were thawed on ice. Plasmid DNA was added then 
the mixture was left on ice for 15-45 mm. The cells were heat shocked at 42°C for 90 
sec then returned on ice for 1-2 mm. Four volumes Luria-Bertani (LB) medium were 
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added and the samples incubated with gentle shaking at 37°C for 45-60 mm. The cells 
were plated on appropriate selective media and incubated overnight at 37°C. 
II F6b. Preparation and Transformation of electrocompetent bacteria 
Preparation: E. co/i were grown overnight in 50 ml of LB at 37'C. The next day 5 ml 
of the overnight culture were added to 2 L of LB and left to grow until the cell density 
reached A550 , then the culture was transferred to ice for 5 mm. Cells were centrifuged at 
4000 x g at 4°C. Cells were washed twice in 100 ml of ice cold 1 mM Hepes pH 7.0 plus 
ice-cold 10% (v/v) glycerol. Cells were collected by centrifugation at 4000 g for 15 mm 
at 4°C, resuspended in 2-3 ml in ice-cold 10% (v/v) glycerol, distributed into 100 p1 
aliquots and stored at -80°C. 
Transformation: 1-5 p1 of DNA were placed in a sterile microcentrifuge tube and chilled 
on ice. Bacterial cells were thawed gently and placed on ice. 50 p1 of bacterial cells were 
transferred to the pre-chilled the microcentrifuge tube containing DNA. The mixture was 
left on ice for 1 min and then transferred to a chilled cuvette (Bio-Rad), gently shaken, 
and placed in into the sliding cuvette holder (Bio-Rad Gene PulserTM).  A pulse of 25 
jiF, 200 92 and 2.5 kV was applied and immediately 450 p1 of LB were added, mixed 
with the cell suspension, transferred to a 1.5 ml eppendorf tube and placed at 37°C for 
30 mm. . The cells were plated on appropriate selective media and incubated overnight 
at 370C. 
II G. Genomic phage library screening and phage DNA 
preparation 
II Gi. Lambda FixIl library screening 
The Lambda Fixil vector is a replacement vector used for cloning large fragments of 
genomic DNA (up to 28 kb in length). This vector, with appropriate inserts, is able to 
grow on strains lysogenic for P2 such as XL1-blue MRA-P2 (the host cell used in our 
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laboratory), a P2 lysogen of XL 1-blue MRA strain. The red and gam genes in the 
Lambda Fixil DNA are located on the stuffer fragment; therefore the wild type phage 
can not grow on P2 cells. When the stuffer fragment is replaced by an insert, the 
recombinant Lambda Fixil phage becomes Red-/Gam-, and the phage is able to grow on 
the P2 lysogenic strain. Therefore, by plating the library on P2 lysogenic cells, only the 
recombinant Lambda Fixil phages will grow. 
For plating, MRA-P2 Cells are grown in LB supplemented with MgSO4 (10 MM) and 
maltose (0.2%) to an 0D600 of 0.5 then centrifuged down and re-suspended in 10 mM 
MgSO4 to an 0D600 of 0.5. Plating cells (200 jil) are mixed with the phage and 
incubated at 37°C for 15 minutes. To this Top agarose (previously melted and kept at 
50°C until required) is added and the mixture is poured quickly onto an LB agar plate, 
which had been previously dried and warmed at 37°C. 
II G2. Performing plaque lifts 
1st round screening: 0.8 tl of phage stock (3.5 x 108 Ill plaque forming units/plate) 
were adsorbed to MRA-P2 cells, then plated on four large 150 mm-agar plates and 
incubated at 37°C for 10 hours. The plates were then chilled and phages transferred onto 
nylon membranes. Duplicate plaque lifts were made. A needle and ink were used to 
prick and mark through the agar for orientation. The phage DNA was denatured by 
soaking the membrane for 2 min with 1.5 M NaCl, 0.5 M NaOH, neutralized for 3 mm 
in 1.5 M NaCl, 0.5 M Tris-Cl/pH 7.5, and washed with 0.2 M Tris/pH 7.5, 2xSSC. The 
DNA was UV crosslinked to the membrane and hybridised with the desired probe 
prepared as discussed in section II C6. Double positive phages (signals present on both 
plaque lifts) were picked. The phages were stored at 4°C in 500 j.tl of SM buffer plus 30 
1.11 of chloroform. 
Further screening: Four sets of dilutions (10'-i 0) of the phage stocks were mixed 
with freshly prepared MRA-P2 cells and plated on 9 cm LB agar plates. Plaque lifts 
were performed following the same protocol used for the 1st  round of screening. Pure 
plaques were obtained after 4 rounds of hybridisation screening. A high titer stock of 
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pure plaques was prepared according to the manufacturer's recommendation 
(Stratagene) and kept at 4°C. Two aliquots were placed in 7% DMSO (Sigma) and 
stored at -80°C. 
II G3. Phage DNA preparation 
Phage DNA was prepared according to the Qiagen Lambda phage maxi prep protocol. 
II H. Genomic DNA and mRNA preparation 
II Hi. Genomic DNA preparation 
Long method: 10 million cells were centrifuged at 800 x g for 5 mm. The supernatant 
media was discarded and the cells were lysed in the DNA lysis buffer by vortexing (10 
mM Tris pH=7, 100 mM EDTA, 0.5% SDS). RNase A was added to a final 
concentration of 20 pg/ml and the samples were incubated at 37°C for 2 hours. 
Proteinase K was then added to a final concentration of 100 j.tg/ml and the samples were 
incubated overnight at 37T. The next day 1 ml of phenol (pH 8) was added, mixed 
thoroughly at first then left to mix gently for 10 min at 4°C. Afterward, the samples were 
centrifuged for 15 min at 1800 x g at 4°C. The upper phase was recovered and the DNA 
was precipitated by adding 1110th  volume of ammonium acetate (10 M) and 2 volumes 
of absolute ethanol. The DNA was washed with 70% ethanol and the pellet was dried 
and re-suspended in sterile water. The DNA was left to dissolve overnight at 4°C. 
Short method: 2 million cells were centrifuged at 800 x g for 5 mm. The supernatant 
media was then removed by aspiration and the cells were lysed in TAIL buffer 
(50 mM Tris/HC1 (pH 8.8), 100 mM EDTA, 100 mM NaCl, 1% SDS) previously 
warmed to 37°C to facilitate the lysis process. Proteinase K was added to a final 
concentration of 100 ig/ml and the samples were incubated overnight at 37°C. The next 
day the samples were mixed by shaking for 5 minutes. Then 500 jfl of 6 M NaCl were 
added and the samples were mixed again by shaking for another 5 minutes. The tubes 
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were centrifuged at maximum speed (20, 000 x g) for 5 minutes at 4°C. The supernatant 
was transferred to a new tube and 250 tl of isopropanol was added. The samples were 
mixed by inverting and centrifuged for 5 minutes at 20, 000 x g. The resulting DNA 
pellet was washed with 500 Ri  of 70% ethanol, air-dried and re-suspended in 100 R' 
sterile water. The DNA was either left to dissolve overnight at 4°C or was incubated at 
37°C for 20 mm (in cases where the DNA was to be used the same day). 
II H2. mRNA preparation 
Long method: 10-20 million cells were centrifuged at 1200 rpm for 5 mm. The 
supernatant media was then removed and the cells were lysed in RNA lysis buffer (4 M 
guanidium thiocyanate, 25 mM Sodium citrate, 0.5% sarkosyl, 0.1 M 13 
mercaptoethanol) while vortexing. The lysate was poured into a 2 ml eppendorf tube, 90 
R' of sodium acetate (2 M; pH 4) and 0.9 ml of water was added and mixed thoroughly. 
Subsequently, 180 R'  of chloroform were added and mixed again and centrifuged for 20 
min at 10, 000 x g at 4°C. The upper phase was recovered to a new eppendorf tube. The 
RNA was precipitated by adding 1 volume of isopropanol, placing the tubes at -20°C for 
1 h and centrifuging for 30 min at 20, 000 rpm at 4°C. The RNA pellets were washed 
with 1 ml 70% ethanol. The pellet was left to air dry and resuspended in 30-50 R1  RNase 
free water. The RNA was quantitated by diluting 4 of stock RNA in 1 ml of water and 
measuring the OD at 260 and 280 nm. OD 260 nm x 10 = RNA concentration in Rg'R1  
Short method: total mRNA was prepared using the TRIzol reagent (Invitrogen) 
according to the manufacturer's recommendations. 
Oligo(A) mRNA preparation: Oligo(A) mRNA were prepared from 1 mg of total RNA 
using Oligotex mRNA Mini or Midi kits following the manufacturer's 
recommendations. 
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Ill. Apoptosis experiments 
liii. 	Apoptosis induction 
Apoptosis was induced in cultured cells by either etoposide (Sigma and Calbiochem) 
treatment (5 iM-100 tM) for 3-5 hours or staurosporine treatment (0.1 tM —10 jiM) for 
5-7 hours. 
1112. 	Loss of plasma membrane assymetry : Annexin V staining 
Annexin V staining was used when investigating for phosphatidylserine (PS) exposure 
(see Chapther I section I B2a). Annexin V staining was carried out using either the 
Annexin-V-Fluos Staining Kit (Roche) or the Annexin V- PE Apoptosis detection kit 
(BioVision) according to the manufacturer's recommendations. 
1113. 	DNA fragmentation analysis 
DNA fragmentation analysis was assessed either by Tunel staining or DNA laddering 
(see Chapter I section I B2b). 
II 13a. Terminal deoxynucleotidyl transferase-mediated dUTP nick 
labeling (Tunel) staining 
Tunel staining was carried out using either Tunel Label (Boehringer Mannheim) or In 
situ cell death detection kit, TMR red (Roche) according to the manufacturer's 
recommendations. 
II 13b. DNA laddering 
Cells were induced to undergo apoptosis for 5-7 hours as described above. At various 
time points cells were centrifuged at 800 x g and immediately lysed in DNA lysis buffer. 
DNA was extracted as described in section II D4, quantified and 5 jig was loaded and 
clectrophoresed on a 1.5 % agarose gel. 
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1114. 	Detection of apoptosis by flow cytometric analysis 
PS exposure and DNA fragmentation were quantified, as described above, by Annexin 
V and Tunnel labelling. After staining, cells were transferred to a 5 ml Polystyrene 
Round-Bottom Tube (Falcon) and, when required, diluted in PBS. Cells were analysed 
using a Becton Dickinson FACS Calibur flow cytometer. A total of 15,000 cells were 
counted at maximum rate of 500 events per second. Data was acquired and analysed 
using the Cell Quest software. 
1115. 	Cell viability assays on DT40 cells 
Cell viability assays were carried out in flat bottom 96 well microtiter plates as follows: 
Al 2 3 4 5 6 7 8 9 10 11 12 
B 
- 	Cell death-inducing drug added by serial dilution 
D from rows 3tol2 
H I 
The 96 wells were filled first with 50 pi of RPMI supplemented with 10% FBS and 1% 
chicken serum. To column 1 an additional 50 t1 of medium were added. The cell death 
inducing drugs etoposide or staurosporine were added to row 3 at final concentrations of 
100 l.LM and 1 tM respectively and in a final volume of 100 tl. 50 jtl of column 3 was 
then taken and mixed with row 3. This was repeated from row 3 to row 12, diluting the 
drug by two-fold each time. A 96 well plate usually served for two assays which were 
conducted in triplicate. Consequently, to rows B-d 50 j.il of cells X eperiment 1 were 
added and to rows E-G 50 tl of cells Y, experiment 2 were added. Plates were left at 
39°C for 24 hours. After incubation, 10 tl of the cell proliferation reagent WST-1' 
(Roche) was added to each well and incubated for an additional 3 hours at 39°C. The 
'Cell proliferation and viability assays use the tetrazolium salt (WST-l). Tetrazolium salts are 
cleaved to formazan by the "succinate-tetrazolium reductase" system which belongs to 
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absorbance was measured using an ELISA plate reader at 420 nm with a reference 
wavelength of 600 nm and the data was analysed using KC' software. 
1116. 	Cell free system 
In the cell free system, isolated HeLa or Jurkat nuclei were incubated with cytosolic 
extracts from caspase-6 or caspase-7 cells (prepared as described in section II E4) and 
analysed either by immunoblotting, or fluorescence microscopy. 
HeLa and Jurkat nuclei were prepared as follows: Cells were centrifuged at 800 x g, 
washed once in PBS, and once in nuclei buffer (10 mM Pipes/pH 7.4, 10 mM KC1, 2 
MM MgCl2, 1 mM DTT, 20 tM cytochalasin B, 1 mM CLAP and 10 j.tg/ml PMSF). 
Cells were transferred to a Dounce homogenizer, allowed to swell by incubating on ice 
for 20 min then lysed by douncing. The state of lysis was assessed by a phase contrast 
microscope (Olympus CI-12). When 90% of cells were judged to be lysed, the nuclei 
were layered over a 30 % sucrose bed and centrifuged at 800 g for 10 mm. Finally, the 
nuclei were resuspended in storage buffer (10 mM Pipes, pH 7.4, 80 mM KC1, 20 mM 
NaCl, 250 mM sucrose, 5 mM EGTA, 1 mM DTT, 0.5 mM spermidine, 0.2 mM 
spermine, protease inhibitors and 50 % glycerol). 
Apoptosis induction: Nuclei were washed twice in MDB buffer (10 mM Pipes/pH 7.0, 
50 mM NaCl, 5 mM EGTA, 2 mM MgCl2, 1 mM DTT), resuspended in MDB buffer 
and divided equally between the samples to be analysed. Apoptotic extracts and an ATP 
regenerating system (2 mM ATP, 10 mM creatine phosphate, 50 tM creatine kinase) 
were added and the mixtures were incubated at 37°C for 1 to 3 hours. 1 il of nuclei were 
fixed in 2 % paraformaldehyde and stained with DAPI. Images were captured using a 
Zeiss Axioplan II microscope and analysed using the IP Lab 3.2.3 software. The 
remainder of each sample was lysed in sample buffer for immunoblotting analysis. 
57 
Genetic analysis of cspase••6 and 7 function in vertebrate 0740 cell line 
	
1117. 	Caspase affinity labelling experiments 
25-30 tg of protein from cytosolic extracts were added to 1 LM zEK(bio)D-aomk 
(Peptide Institute, Kyoto Japan) and incubated for 15 min at 37°C. 5 pl of Laemmli 
buffer were added and samples were boiled for 5 min then separated on a 12% 
SDS/PAGE and proteins were transferred to a nitrocellulose membrane as described in 
section II E4. After transfer, the membrane was blocked in PBS/5% milk for 45 mm, 
washed thoroughly and incubated with horseradish peroxidase-linked streptavidin 
(Sigma) for 3 h at 25°C. The signal was revealed by ECL. 
1118. 	Caspase activity assays 
Caspase activity assays were performed in Professor Scott Kaufmann's laboratory at the 
Mayo Clinic, Rochester, MN USA. Cleavage of DEVD-AFC (Biomol, Plymouth 
Meeting, PA), VEID-AFC (Enzyme Systems Products, Dublin, CA) and LEHD- AFC 
(Enzyme Systems Products, Dublin, CA) was assayed as previously described (Kottke et 
al., 1999; Martins et al., 1997a). DEVD-AFC, VEID-AFC and LEHD-AFC are synthetic 
tetrapeptide fluorogenic substrates that are used to identify and quantitate caspase-3,- 6 
—7 activity respectively in apoptotic cell lysates. Caspase-3, -6 —9 cleave selectively their 
appropriate tetrapeptide between D and AFC releasing the fluorescent AFC (7-amino-4-
trifluoromethyl-coumarin dye) which can be measured in cell lysates by 
spectrofluorometry. 
In brief, 50 ig of cytosolic protein in 50 p1 buffer A (25 mM HEPES/pH 7.5 at 4°C, 5 
MM MgCl2, 1 mM EGTA, 1 mM PMSF, 10 tg/ml pepstatin A, and 10 j.ig/ml leupeptin) 
or 0 ig protein (as a blank) was diluted with 225 tl of freshly prepared buffer B (25 mM 
HEPES/pH 7.5, 0.1% (wlv) CHAPS, 10 mM DTT, 100 U/ml aprotinin, 1 mM PMSF) 
containing 100 M substrate and incubated for 2 h at 37°C. After reactions were 
terminated by addition of 1.225 ml ice cold buffer B, fluorescence was measured using 
an excitation wavelength of 360 nm and emission wavelength of 475 nm. Standards 
containing 0-15 nmoles of AFC were utilized to determine the amount of fluorochrome 
released. 
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Chapter III: Generation of caspase-64- and 
caspase-74- DT40 cells 
Ill A. Introduction 
In the last ten years several natural caspase inhibitors were discovered and used to 
study protease functions in apoptotic execution (reviewed in (Rudel, 1999). In 
addition, genetic approaches were used to knockout caspase genes in mice (see 
Chapter 1 section 1E2). The results showed that caspases-3 and -9 are crucial to 
mouse brain development and that caspase-8 plays an essential role in heart 
development (Earnshaw et al., 1999; Zheng and Flavell, 2000). An alternative system 
that we have used to study the role of caspases in apoptosis is gene targeting using 
the chicken DT40 lymphoma cell line. 
The aim of my project is the genetic analysis of caspase function by gene knockout in 
the DT40 cell line. No DT40 caspase knockout had been published when my work 
started with participation in an ongoing caspase-6 knockout project. Dr. Pascal Villa, 
a former postdoctoral in the Earnshaw laboratory, had screened a genomic Lambda 
Fixil DT40 library and isolated several phages containing the chicken caspase-6 
coding region. I started my work in collaboration with Dr. Sandrine Ruchaud, another 
postdoc in the Earnshaw laboratory, who had followed up the caspase-6 knockout 
project. An interesting second knockout that we decided to work on was caspase-7 
since it is also involved in the execution phase of apoptosis. I spent the last two years 
on that project. 
As discussed in the Introduction to this thesis, both caspases-6 and -7 have an active 
role in the execution of the death pathway. Knocking out the genes responsible for 
their production gives us additional insights into their role in apoptosis. We aimed for 
the elimination of the gene responsible for the production of caspase-6 and —7 and 
subsequently to study the morphological and biochemical characteristics of apoptosis 
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in caspase-6 and -7 cells. The work on caspase-6 started with mapping of 
previously isolated phages containing the genomic locus and the caspase-7 project 
started with chicken caspase- 7 (Expressed sequence tag) EST sequencing and 
screening a lambda Fixil genomic library to isolate phages containing the caspase-7 
locus. Since some of the initial steps of the caspase-6 and —7 knockout project were 
similar, this chapter will discuss the two projects simultaneously and later Chapters 
IV and V will be allocated to the description and characterisation of each of the, 
caspase-6 and -7, knockout cell lines. 
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Ill B. Isolation of lambda phages containing caspase-6 and 
caspase-7 loci 
III Bi. Chicken caspase-6 cDNA 
As stated above caspase-6 genomic phages had been isolated when I joined the 
capase-6 knockout project. Sequencing of the caspase-6 cDNA revealed that it is 
67% homologous to human caspase-6 (GeneJockey, sequencing processor). 
III B2. Chicken Caspase-7cDNA 
A chicken caspase-7 EST was obtained from university of Delaware (Newerk, 
Delaware Newark, USA). The first step was to amplify the plasmid in order to have 
sufficient amounts of DNA to sequence and use for future studies. Top 10 competent 
E.coli cells were transformed with the EST-containing plasmid (see Chapter II 
section II F6a). A 2.2 Kb insert was removed by a double digest with restriction 
enzymes NotI/EcoRI (see Chapter II Section II Cia). The EST was sequenced by 
automatic sequencing using the ABI system (Biosystem) (see Chapter II section II 
C5). The resulting sequences were analyzed by nucleotide sequence comparisons 
using the NCBI/BLASTN advanced search engine. The results showed that the EST 
contains the complete open reading frame (ORF) and the 3' untranslated region 
(UTR). Alignment with human caspase-7 showed the two proteins are 66% 
homologous (GeneJockey, sequencing processor). 
111 133. Restriction enzyme digestion of caspase-7 EST 
A series of restriction digests were performed in order to map restriction sites within 
the caspase-7 cDNA in order to design probes for genomic library screening. Figure 
3.1 is a preliminary map of the caspase-7 cDNA. Accordingly, a 5' probe was chosen 
for screening the genomic DT40 lambda Fixil library. The vector was digested with 
KpnI and the resulting 1.2 kb band was removed and purified using the Qiagen gel 
purication kit (Fig 3.1). 
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Figure 3.1: Caspase-7 cDNA 




3 ,  
Kpnl EcoRl Hindlil 	 Kpnl 	Xbal 	 NotI 
Start 	 Stop 
2.2 kb 
Fig 3. 1 Schematic representation of caspase-7 cDNA cloned into 
pCDNA3 (Invitrogen). The line in red represents the probe used to screen 
the lambda FixIl library 
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111 134. Lambda FixIl library screening for caspase-7 gene locus 
I next screened a DT40 genomic lambda Fixil library in order to isolate clones 
covering the caspase-7 genomic locus. My aim was to use 5' and 3' genomic DNA 
fragments flanking the caspase gene to subsequently construct the caspase-7 
targeting vector. The genomic library was titered according to the Stratagene 
instruction manual. The library titer was 4.48 x 108  plaque forming units/ml. 
Approximately two million phages were screened from the library. 
After the first screening, using the 1.2 kb cDNA fragment as a probe, we isolated 
fourteen positive phage plaques. After four rounds of screening five pure plaques 
were isolated and, among the five phages, three were amplified, titred and stored at - 
80°C. 
Ill C. Mapping and sequencing of the caspase-6 and - 7 
genes 
At first, the caspase-6 and -7 genes were mapped by performing a series of partial 
digestions with restriction enzymes of interest followed by Southern analysis and 
hybridisation with oligo nucleotide probes to T3 and T7 promoters in the ? phage 
arms containing the inserts (see Chapter II Sections II Cib and II C6a). A 
representative result of such a restriction digest is shown in figure 3.2 where SacI was 
the enzyme of choice. Partial mapping was performed on four caspase-6 phages and 
three caspase-7 phages. The partial mapping allowed phages to be selected for 
sequencing at GATC (GATC Biotech, Germany). One phage for each caspase was 
selected. The requested amount of genomic DNA was prepared and sent for 
sequencing. 
The entire loci, 18 kb for caspase-6 and 19 kb for caspase-7, were sequenced and the 
position of the exons determined by comparison with the cDNA sequence using 
GeneJockey, sequencing processor. The caspase-6 gene appeared to be at least 8800 
bp in length and contains 8 exons (Fig. 3.3A). the caspase-7 sequence covered the 
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Figure 3.2: Mapping of caspase-6 locus by partial digest 
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Fig 3.2: Caspase-6 gene locus mapping on phage 12, A, Schematic 
representation of Lamda Fixll showing the multiple cloning site and the T3 
and 17 DNA sequences flanking the insertion region B, Ethidium Bromide 
picture of the gel under UV. C, Southern blot of the gel presented in B. 
The membrane was hybridised with a radiolabelled T3 oligo nucleotide 
primer. 
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III D. Knockout vectors 
The caspase replacement vectors were designed to contain two regions of homology 
to the targeted gene with the 5' end upstream and 3' end downstream to the coding 
genomic locus. These two genomic fragments were located on either side of 
selectable markers, which gives histidinol, blasticidin or puromycin resistance. Both 
of the genomic DNA fragments were cloned in the same orientation, 5'-3', with 
respect to the gene (Fig 3.3 and 3.4). 
III Dl. Caspase-6 knockout vectors 
To disrupt the caspase-6 gene we constructed a targeting vector in which a resistance 
cassette (puromycin or histidinol) was flanked by a 5' genomic arm situated upstream 
from exon 2 and a 3' genomic arm situated downstream of the stop codon (Fig. 3.3B). 
Targeted integration of these constructs Casp6puro and Casp6his would remove a 
7211 bp gene fragment containing the majority of the open reading frame (888 bp of 
915 bp) and part of the 3' untranslated region. 
A 3' screening strategy was designed to screen for proper targeting events. As shown 
in Figure 3.3B, a BamHJ restriction digest of genomic DNA followed by Southern 
analysis using a 3' external probe would recognises a 7.7 kb band for wild type DT40 
cells and a 5.3 kb or 2.7 kb band after integration of the Casp6puro or Casp6his 
constructs respectively. 
III D2. Caspase-7 knockout vectors 
To disrupt the caspase- 7 gene, we constructed targeting vectors in which a resistance 
cassette (blasticidin or histidinol) was flanked by a 5' genomic arm situated upstream 
of the first exon found in the phage clone and a 3' genomic arm situated downstream 
of the stop codon (Fig 3.4B). Targeted integration of these constructs, termed 
Casp7blast and Casp7his, would remove a 3700 bp gene fragment containing the 
majority of the open reading frame (786 bp of 930 bp). Following insertion of these 
vectors, only the first 13 
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Figure 3.3: Structure and targeting strategies of the 
Gallus gallus caspase-6 gene 
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Fig 3.3: A, Structure of the chicken caspase-6 gene together with the 
targeting vectors and homologous recombinants containing either the 
Puromycin or the Histidinol cassette. B, Schematic representation of 3' 
screening strategy using BamHl digest. Line in grey represents the 3' 
external probe. 
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Figure a4: Structure and targeting strategies of the 
Gallus gal/us caspase-7 gene 
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Fig 3.4: A, Partial structure of the chicken caspase-7 gene and the 
knockout constructs containing the 5' and .3' arms separated by a 
resistance cassette (Blasticidin or Histidinol). B, Schematic 
representation of 3' screening strategy using EcoRl digest. Line in green 
represents the 3' external probe. C, Schematic representation of 5' 
screening strategy using a double BamHl and Ndel digest. Line in red 
represents the 5' external probe. 
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67 
Genetic analysis of caspase-6 and 7 function in vertebrate DT40 cell line 
amino acids of the enzyme prodomain and 3 amino acids of the large subunit could 
potentially be expressed. However, since caspase are enzymes and their activation 
requires proteolysis followed by processing and association of two subunits to form 
the active protease (see Chapter I Section I D), it is highly unlikely that the short 
peptide, if expressed, would be functional. 
A 3' and a 5' screening strategy were designed to screen for proper targeting events. 
As shown in Figure 3.4, an EcoRI restriction digest on genomic DNA followed by 
Southern analysis using a 3' external probe would recognise an 11 kb band for wild 
type DT40 cells and a 4.7 kb band after integration of the Casp7puro or Casp7bsr. A 
double BamHI/NdeI restriction digest followed by Southern analysis using a 5' probe 
would recognise a 6.5 kb for wild type cells and a 5.5 kb band for targeted alleles 
(Fig 3.4 Q. 
Ill E. Generation of caspase-6' and caspase-7' cells 
Ill El. Generation of Caspase-6 deficient DT 40 clones 
In order to isolate heterozygous caspase-6 clones, wild type DT40 cells were 
transfected with the Casp6puro or Casp6his constructs and purornycin or histidinol 
resistant clones were isolated. As explained in Section III Dl, targeted events were 
recognised by BamHI digestion followed by Southern analysis using a 3' probe. As 
shown in figure 3.5, the 3' external probe recognised a 7.7 kb band corresponding to 
the wild type allele and a 5.3 kb band after targeted integration of the Casp6puro. The 
targeting efficiency for the first allele was 8% . For some unknown reasons, we were 
unable to isolate heterozygous clones using the Casp6his construct. Several attempts 
were made to generate a caspase-6 deficient cell line using different knockout 
constructs but after screening 350 clones no double targeting events were isolated. 
These results implied that caspase-6 might be an essential gene in DT40 cells. Thus 
we decided to transfect caspase-6 heterozygote clones with the caspase-6 cDNA 
under control of the TetA tetracycline repressable system (see Material and Method 
Section II 134). The cloning was done by Dr. Sandrine Ruchaud. At the end we 
obtained several clones expressing caspase-6:GFP under tetracycline control. 
The clones obtained contained the following expression plasmids: 
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The clones obtained contained the following expression plasmids: 
- 	7x tet casp6 + tTA3 (1 clone selected called I) 
- 	7x tet casp6 + tTA4 (1 clone selected called II) 
- 	3x tet op-casp6-EGFP + tTA3 (2 clones selected called III and IV) 
- 	7x tet casp6:EGFP + tTA3 (1 clone selected called V) 
For clones I-TV, Dr Sandrine Ruchaud checked the expression of exogenous caspase-
6 by caspase activity affinity labelling (Fig 3.6) and by immunofluorescence for 
clone V. She then confirmed that the repression of the caspase-6 transcript was 
effective after the addition of 1 [LM doxycycline for 48 hours. Clones I to V were 
transfected with a second caspase-6 knockout vector encoding histidinol resistance. 
The results of transfection are represented in Table 3.1: 





clones 	Clones screened Caspuse-6 
deficient cells 
Ira 
The efficiency of second allele targeting was 4% as expected (half of that obtained 
for first allele targeting). Subsequently, clones 1126 and V63 were used to investigate 
of the role of caspase-6 in apoptotic execution of DT40 cells. 
Following closer inspection we were surprised to find out that clone 1126 had lost the 
caspase-6 cDNA. Since I was involved in the analysis of that particular clone, the 
following sections will be focused on the analysis of caspase-6 deficiency in clone 
1126 (Fig 3.7A). 
In this clone, loss of caspase-6 expression was confirmed by Dr Ruchaud by 
Northern blot analysis and by iinmunoblotting analysis (Fig 3.713, C). 
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Figure 3.5: First allele targeting of Gallus gallus caspase-6 gene 
S.- 
	
AW&Miwa 1- 	:• 4-7.7 kb low 
1 	2 	3 	4 	5 
Transfected cells 
Fig 3.5: Southern blot analysis of DNA digested with BamHl using the 3' 
genomic external probe represented in 3.3 B. Lanes 3 and 5 are 
examples of first allele replacement. (*) Heterozygote clone used for 
second allele targeting. 
Figure 3.6: Caspase-6":casp-6:cDNA and Caspase-6--':casp-6:EGFP 
stable cell lines 
Fig 3.6: Labelling of active caspases by zEK(bio)D-aomk and separation 
on SOS-PAGE. Apoptotic extracts were prepared form clones (l-IV) 
treated with 10 pM etoposide for 4 hours in the presence or absence of 1 
M doxycycline. Endogenous biotinylated protein expression is used as 
gel loading control. 
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Fig 3.7: A, Southern blot analysis of DNA digested with Barn HI, using the 3' 
genomic external probe Apa I-Barn HI represented in 3.313. Lane 2 shows the 
replacement of one of caspase-6 alleles with the targeting construct, lane 3 
shows the disappearance of the WT alleles replaced by the proper targeting of 
homologous knockout constructs. B, Northern blot analysis showing chicken 
caspase-6 and -3 mRNA expression.Caspase-3 mRNA expression levels are not 
affected by the loss of caspase-6. Caspase-6 mRNA could not be detected in 
null cells. C, Immunoblotting of caspase-6 using a polyclonal antibody directed 
against the large subunit of the enzyme (R549). Heterozygote clones show a 
diminished caspase-6 protein expression. In null cells no caspase-6 protein 
could be detected. 
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Ill E2. Generation of caspase-7 deficient DT40 clones 
The caspase-7 gene deletion was performed by homologous recombination in the 
chicken B cell lymphoma cell line DT40. Wild type DT40 cells were transfected 
with the Casp7his and Casp7brs constructs and histidinol and blasticidin resistant 
clones were isolated. Homologous targeting events were recognised by Southern blot 
analysis after an EcoRl or a double BamHI/NdeI restriction digestion of genomic 
DNA digest using a 3' or 5' probe respectively (see above Section III D3). As shown 
in Figure 3.8A, the 3' probe recognised an 11 kb band corresponding to the wild type 
allele and a 4.7 kb band after targeted integration of the Casp7blast or Casp7his 
constructs. The 5' probe detected a 6.5 kb in WT cells and a 5.5 kb band for targeted 
alleles (Fig 3.8 B). The targeting efficiency for the first allele of 1.4% was similar for 
both knockout constructs. The targeting efficiency for the second allele was an 
unexpectedly high 10%, Several caspase-7 deficient clones were isolated (Fig 3.8A, 
B). 
Our aim was to confirm caspase-7 deficient clones by Northern analysis (see Chapter 
II section or by RT-PCR (see Chapter II Section II D2) . Therefore Northern blot 
analysis and RT-PCR was performed on total and polyA mRNA (see Chapter II 
section 11 1-12) from wild type and caspase-7 deficient clones. After several attempts 
using the complete caspase-7 cDNA or two other different probes amplified by PCR 
from caspase-7 cDNA using NKC75 and NKC73 or NP5 and NP3 (see table 2.1 in 
chapter II, material and methods) we were unable to detect any caspase-7 mRNA in 
wt DT40 cells. The possibility that we failed to detect any caspase-7 mRNA due to 
the probes we used was ruled out by using DU249 and MSB, two other chicken cell 
lines, as positive controls (Fig 3.9A). Our RT-PCR attempts using primers NKC75 
and NKC73 or NP5 and NP3 as primers gave exactly the same results (Fig 3.913). 
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Figure 32: Targeting of Gallus gallus caspase-7 gene 
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Fig 3.8: A, Southern blot analysis of DNA digested with EcoRl, using the 3' 
genomic external probe represented in 3.413. B, Southern blot analysis of DNA 
digested with Barn HI and NdeI, using the 5' genomic external probe represented 
in 3.40 
Lanes 2 and 3 are examples of heterozygote clones where one of the caspase-7 
alleles has been properly targeted. Lanes 4-7 are examples of null clones. WT 
alleles are not present anymore and only targeted alleles are detected. 
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Fig 3.9: A, B, Northern blot analysis using total RNA (A) or PolyA RNA (B) from WT, 
heterozygous, caspase-7', caspase-71:casp-7:cDNA, MSB and DU249 cells. The 
probe used was caspase-7 OAF. C,D, RT-PCR on RNA from WT, heterozygous, 
caspase-7 , caspase-71:casp-7:cDNA, MSB and DU249 cells.-Primers used were 
NKC73/NKC75 (C) and NP3/NP5 (D) to amplify the caspase-7 OAF and caspase-
7 small subunit respectively .No caspase-7mRNA could be detected, by Northern 
blot analysis or AT-PCR in WT DT40 cells. Caspase-7 mANA was detected in 
MSB, DU249 and caspase-71.casp-7:cDNA cells. 
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Ill F. Discussion 
III Ft Generation of a caspase-6 deficient DT40 cell line 
The results of this chapter report the isolation of a caspase-6 deficient DT40 cell line. 
The targeting efficiency of caspase-6 allele was not as expected. The first allele 
targeting occurred with a frequency of 8 %, therefore we expected a 4% efficiency of 
targeting for the second caspase-6 allele. However, when the second knockout 
construct was transfected into caspase-6 cells and 350 clones were screened, it was 
not possible to isolate any clone where the second caspase-6 allele was replaced by 
knockout constructs. When the same experiment was repeated in the absence of 
selection for the first marker, gene targeting was possible and occurred at a 
frequency of 16 %, however, all recombinants had re-targeted the first allele. 
This strongly suggested that the caspase-6 gene is essential in DT40 cells. Therefore, 
heterozygotes were transfected with cDNAs expressing caspase-6 or caspase-
6:EGFP and stable cell lines were isolated. These caspase-6 heterozygous clones 
expressing exogenous caspase-6 were transfected with the second replacement 
vector. Only then it was possible to target the second allele (7.5% targeting 
efficiency). This was consistant with the notion that caspase-6 might be an essential 
gene. Surprisingly, one of the caspase-6 deficient clones isolated, subsequently clone 
11 26, initially expressing caspase-6, lost the exogenous sequences. Clone 11 26 was 
confirmed to be a caspase-6 deficient clone by Southern, Northern and 
Immunoblotting analysis, as well as caspase-6 activity assay. The fact that clone 1126 
grew normally indicated that caspase-6 was not essential as first thought but suggests 
that caspase-6 might possibly have a role in homologous recombination (see Chapter 
VI Section VI Cl for further details). 
Ill F2. Generation of a caspase-7 deficient DT40 cell line 
The results of this chapter also report the isolation of caspase- 7 deficient DT40 cell 
lines. The targeting efficiency for the first allele was 1.4%, lower than expected 
when compared to first allele replacement of caspase-6 (8%) and CAD ( 10%) 
(Samejima et al., 2001). Surprisingly, targeting the second allele of caspase-7 using 
the same replacement vectors with different selectable markers occurred at a high 
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frequency of 10% (see Chapter V and VI Section VI C3 for further discussion). 
Targeted events were verified for proper integration of the replacement vector at the 
3' and 5' ends of the locus. When Northern and RT-PCR analysis were subsequently 
conducted to confirm the loss of caspase-7 mRNA , the caspase-7 transcript could 
not be detected in wild type DT40 cells (see above section III D2). The logical 
explanation behind this result is that caspase-7 is expressed at very low levels and 
below the threshold of sensitivity for the techniques used. We were aware that the 
inability to verify that caspase-7 is expressed in DT40, and confirm the transcript is 
lost in caspase-7 deficient cells, could impose a problem in subsequent analysis of 
caspase-7 cells. To overcome this problem, caspase-7 cells were transfected with 
a construct containing the caspase-7 cDNA fused to EGFP. We then isolated stable 
caspase-7:casp-7:EGPF-expressing cell lines. These cell lines were then used to 
confirm that phenotypes observed after the loss of caspase-7 are rescued by 
expressing exogenous caspase-7, providing the proof that the phenotypes observed 
were due to loss of caspase-7. 
Ill F3. The choice of the DT40 knockout system to study caspase 
functions 
Genetic knockout is an attractive approach to study caspase function since the 
thirteen caspases identified are highly homologous and the use of specific inhibitors 
is not completely reliable to study specific caspase functions. Caspase.-6 and caspase-
7 knockout mice have been generated, however, it was apparently problematic to 
draw any conclusion regarding specific caspase function (see review (Zheng et al., 
1999)). Caspase-6 mice had no phenotype and caspase-T mice were very early 
embryonic lethal. Thus the choice of gene knockout in DT40 cells is ideal, since it 
allows the exploration of the contribution of these caspases to apoptotic execution at 
a cellular level. As discussed in greater detail in the introduction to this thesis, the 
high homologous recombination, stable genotype, small genome size, 9-12 hour 
doubling time and the possibility to generate multiple knockouts persuaded us to 
adopt this system for the study of caspase-6 and caspase-7 functions. 
At this point, one unavoidable question is why the use of a time consuming knockout 
approach when protein knockdown by RNA interference (RNAi) and small 
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the same replacement vectors with different selectable markers occurred at a high 
frequency of 10% (see Chapter V and VI Section VI C3 for further discussion). 
Targeted events were verified for proper integration of the replacement vector at the 
3' and 5' ends of the locus. When Northern and RT-PCR analysis were subsequently 
conducted to confirm the loss of caspase-7 mRNA , the caspase-7 transcript could 
not be detected in wild type DT40 cells (see above section III D2). The logical 
explanation behind this result is that caspase-7 is expressed at very low levels and 
below the threshold of sensitivity for the techniques used. We were aware that the 
inability to verify that caspase-7 is expressed in DT40, and confirm the transcript is 
lost in caspase-7 deficient cells, could impose a problem in subsequent analysis of 
caspase-7-1- cells. To overcome this problem, caspase-7 cells were transfected with 
a construct containing the caspase-7 cDNA fused to EGFP. We then isolated stable 
caspase-7"":casp-7:EGPF-expressing cell lines. These cell lines were then used to 
confirm that phenotypes observed after the loss of caspase-7 are rescued by 
expressing exogenous caspase-7, providing the proof that the phenotypes observed 
were due to loss of caspase-7. 
III F3. The choice of the DT40 knockout system to study caspase 
functions 
Genetic knockout is an attractive approach to study caspase function since the 
thirteen caspases identified are highly homologous and the use of specific inhibitors 
is not completely reliable to study specific caspase functions. Caspase-6 and caspase-
7 knockout mice have been generated, however, it was apparently problematic to 
draw any conclusion regarding specific caspase function (see review (Zheng et al., 
1999)). Caspase-6 mice had no phenotype and caspase-T mice were very early 
embryonic lethal. Thus the choice of gene knockout in DT40 cells is ideal, since it 
allows the exploration of the contribution of these caspases to apoptotic execution at 
a cellular level. As discussed in greater detail in the introduction to this thesis, the 
high homologous recombination, stable genotype, small genome size, 9-12 hour 
doubling time and the possibility to generate multiple knockouts persuaded us to 
adopt this system for the study of caspase-6 and caspase-7 functions. 
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Chapter IV: Analysis of caspase-6 DT40 cells 
IV A. Introduction 
Caspase-61 , first identified in 1996 as the novel cysteine protease (Fernandes-
Alnemri et al., 1995a), was classified as a member of the effector caspase family 
because of its short prodomain. As described in further detail in the Introduction to 
this thesis, the first substrates identified for caspase-6 were the nuclear lamins (Orth 
et al., 1996; Takahashi et al., 1996). Analysis of caspase-6 function showed that this 
enzyme is involved in lamin disassembly and nuclear envelope breakdown during 
apoptotic execution (Cross et al., 2000; Duband-Goulet and Courvalin, 2000). 
Subsequent studies identified other caspase-6 substrates, however, in general, these 
proteins are also cleaved by other caspases, typically caspase-3, and the only 
substrate thought to be cleaved exclusively by caspase-6 remains the one of the first 
identified, lamin A/C (Slee et al., 2001; Takahashi et al., 1996). 
As described in Chapter III, a DT40 cell line in which both caspase-6 alleles were 
targeted allowed the in vivo and in vitro analysis of the role of caspase-6 role in 
apoptosis. Although no caspase-6 knockout had been published, one review referred 
to caspase-6 null mice (Zheng et al., 1999). In this review the authors reported that 
caspase-6 mice are no different than wild type mice in all the cell death aspects 
investigated and concluded that there is no phenotype linked to disruption of the 
enzyme. The powerful DT40 knockout system provided the advantage of analysing 
the role of caspase-6 at a cellular level and allowed a detailed study of the enzyme 
functions in apoptosis, possibly revealing details that could pass unnoticed while 
analysing knockout animals. 
This chapter focuses on the characterisation of caspase-6 deficient DT40 cell lines. 
'Caspase-6 was originally named Mch2 (mammalian ced-3 homologue 2) 
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Before proceeding any further, I would like to point out once more that Dr. Ruchaud 
was the main person involved in the analysis of the phenotype. I worked under Dr. 
Ruchaud's supervision while analysing the phenotype of caspase-6 deficient DT40 
cell lines. 
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IV B. Phenotypic analysis of caspase- DT40 cells 
IV Bi. Apoptotic morphology 
To address whether caspase-6 deficient cells display any differences in apoptotic 
morphology when compared with wild type DT40 cells, caspase-6 and wild type 
cells were induced to undergo apoptosis by incubation with 10 .tM etoposide for five 
hours. Surprisingly, no differences were noted in the aspects of apoptosis studied. 
The timing and extent of chromatin condensation (Fig. 4.1A), as well as DNA 
fragmentation into a nucleosomal ladder (Fig. 4.1 B), were similar. 
As stated above, lamins are the best known substrates for caspase-6, especially lamin 
A, which is thought so far to be cleaved only by this caspase. Many lymphoid cells, 
however, do not express lamin A (Guilly et al., 1987; Kaufmann, 1989a), providing a 
potential explanation for the lack of an effect on nuclear apoptosis when caspase-6 
was deleted in DT40 cells (a B lymphocyte derived cell line) 
IV B2. Lamin A, Bi and B2 expression in DT40 cells 
In order to verify the possibility that DT40 cells lack lamin A, a polyclonal chicken 
anti-lamin A antiserum (provided by Dr. Reimer Stick) was used to assay for the 
expression of the protein by immunoblot analysis. As shown in Figure 4.2A, chicken 
lamin A antibody failed to detect lamin A in DT40 cells. Immunoblots with a 
monoclonal anti-human lamin A antibody detected a protein migrating at around 66 
kDa in DT40 cells while nothing was detected by using this antibody in chicken 
muscle tissue. On the other hand a strong expression of lamin B2 in DT40 cells was 
detected when compared to chicken muscle tissue. This highly expressed lamin B2 
(migrating at 66 kDA) might be recognized by the anti-human lamin A antibody 
giving this cross reacting band. In control experiments, lamins A and C were readily 
detected in HeLa cells, but not in Jurkat T-lymphoma cells (Fig. 4.2A). 
Genetic analysis of caspase-6 and -7 function in vertebrate 0T40 cell line 
Figure 4.1: Apoptosis in caspase-6 deficient DT40 cells 
Wt 	 ( -I-) M 








Fig 4.1: A, DAR staining of wild type and caspase-6 cells treated with 10 PM 
etoposide for 4 hrs. B, DNA fragmentation analysis during 10 PM etoposide 
time course on wild type (WT) and caspase-6 (-I-) cells. No difference in the 
timingand extent of DNA laddering were noted between WT and caspase-6 
deficient cells. 
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IV B2a. Lamin B  and B2 cleavage in apoptotic caspase-e cells 
Lamin B  and B2 cleavage during apoptotic execution was assessed after incubating 
caspase-6 cells and wild type DT40 cells with 10 j.tM etoposide. As shown in 
Figure 4.213, lamin BI and B2 were cleaved when apoptosis was induced by 
etoposide in both wild type and caspase-6 cells but not to the same extent. Lamin 
B2 is almost completely cleaved in wild type, but only cleaved to about 50% in 
caspase-6 cells (Fig. 4.213). This later observation is consistent with the fact that 
caspase-6 is known to be partly involved in the cleavage of B-type lamins. 
Was the lack of lamin A in DT40 the reason why caspase-6 deficeint cells displayed 
no diffrence in apoptosis when compared to wild type DT40 cells? Ideally we 
wanted to transfect caspase-6 deficient DT40 cells with chicken lamin A cDNA and 
assess in vivo the role of caspase-6 in lamin A cleavage. However, no chicken lamin 
A was available and, after an attempt of transfecting DT40 cells with human lamin A, 
the localisation and processing of human lamin A in chicken cells was not 
convincing. Therefore, to answer this question we turned to use of an in vitro cell-
free system (see below and Chapter II Section II E2 of Chapter II). 
IV C. Analysis of apoptosis in caspase-6' cells in a cell free 
system 
In order to further examine the role of lamin cleavage in nuclear disassembly, a cell-
free system in which HeLa cell nuclei were induced to undergo apoptotic 
morphological changes in the presence of extracts from wild type and caspase-6 
DT40 cells was used. To perform this analysis, cytosolic extracts (Lazebnik et al., 
1993) were prepared from wild-type, caspase-6 and caspase-6 DT40 cells 
following exposure to etoposide or staurosporine for varying lengths of time. 
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Figure 42: Lamin 81 and 82 cleavage 
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Fig 4.2: A, Immunoblot analysis of DT40, Jurkat and HeLa lysates 
together with chicken muscle tissue lysate using the monoclonal antibody 
to human laminA/C (JOL2), chicken lamin a (4134-11) or chicken lamin B2 
(2138-17), B, Immunoblot analysis of wild type DT40 and caspase-6 cells 
treated or not treated with 10 pM etoposide at for 4h, using monoclonal 
antibodies to chicken lamin Bi and B2 (clone L-5 and 2138-17 
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IV Cl. Characterization of cytosolic extracts 
Extracts were characterized in terms of caspase-6 expression and activation, and for 
caspase activity. Immunoblotting analysis revealed that the caspase-6 in apoptotic 
extracts is processed: active caspase-6 (large subunit) appeared at 20 kDa in both the 
wild type and heterozygous extracts (Fig. 4.3A). Labeling of caspases using 
zEK(bio)D-aomk confirmed the strong activation of several caspase species in these 
extracts, with a major labeled band appearing at 20 kDa. Caspase-6 and caspase-3 
have been shown to be the major effector caspases activated during apoptosis 
(Faleiro et al., 1997; Martins et al., 1997b). Interestingly, the overall level of caspase 
labeling with zEK(bio)D-aomk was significantly reduced in caspase-6 extracts 
relative to that seen in wild type and caspase-6 " extracts (Fig. 4.3A). This could 
indicate either that caspase-6 is the major caspase activated in DT40 cells under 
these conditions, or that caspase-6 is required for the activation of other caspases in 
these cells. In an independent approach, caspase-6-like activity was assessed in the 
laboratory of Professor Scott Kaufmann at the Mayo Clinic, Rochester, MN, USA, 
by measuring VEID-AFC cleavage (Fig 4.3B). This activity was substantially 
decreased in extracts from the caspase-6"" cells. Although a low level of activity 
remained, control experiments (Fig. 4.3C) indicated that cleavage of VEID-AFC by 
caspase-3 is sufficient to account for this. Interestingly, extracts from the caspase-6-
/- cells also showed a modest reduction in the ability to cleave DEVD-AFC, a 
substrate usually considered to be specific for caspase-3-like enzymes. Control 
experiments (Fig. 4.3C), indicated that loss of cleavage of DEVD-AFC by caspase-6 
might account for this decrease in activity, although the results shown in Fig 4.3A 
raise the possibility that deletion of caspase-6 also results in a decrease in the level of 
caspase-3 activation in these cells. 
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Figure 4.3: Characterization of caspase-6 apoptotic extracts 
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Fig 4.3 : A, Caspase-6 expression analysis by immunoblothng in extracts 
from wt, (+1-) and (-I-) cells treated with 10 pM etoposide or diluent for 5 h. 
When caspase-6 in the apoptotic extracts is processed, the antibody 
(R549) recognises the large subunit at around 20 kDa. The lower panel 
shows the labeling of active caspases by zEK(bio)D-aomk. a-tubulin 
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Figure 4.3(continued) Characterization of caspase-6 apoptOtiC extracts 
Fig 4.3: B, Measurement of DEVD-AFC and VEID-AFC cleavage activity 
in cytosol from 10 pM etoposide-treated WT, caspase-6' and caspase-6 
DT40 cells. Similar results were obtained when cytosOl was prepared 
from staurosporine-treated DT40 clones (data not shown). c, Evaluation 
of the selectivity of recombinant caspases-3 and —6 toward DEVD-AFC 
and VEID-AFC. Note the substantial cleavage of VEID-AFC by caspase-3 
and DEVD-AFC by caspase-6 under widely used reaction conditions 
despite the relatively low affinity of the enzymes for these non-preferred 
substrates. 
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IV C2. Classification of apoptotic nuclei according to their apoptotic 
morphology 
To determine whether apoptotic extracts lacking caspase-6 were able to induce 
apoptotic morphology, first, apoptosis in HeLa nuclei was defined as four sequential 
stages (I-IV) depending on the chromatin condensation stage (Fig 4.4A). Second, the 
morphology of nuclei following exposure to extracts from etoposide-treated wild 
type, heterozygote and caspase-6 cytosolic extracts, after 2 hours of incubation at 
37°C was scored according to the chromatin condensation stage (Fig. 4,4A, left). 
After incubation in extracts from apoptotic wild type cells, 22 ± 11% of HeLa nuclei 
displayed condensation of chromatin into discrete peripheral clumps (stage III) and 
78 ± 14% had been fragmented into small membrane bound vesicles (stage IV). 
Similar results were observed in extracts from apoptotic caspase-6 cells, except 
that more nuclei displayed discrete clumps of peripheral chromatin and fewer had 
fragmented into apoptotic bodies. On the other hand, the caspase-6 extracts 
revealed clear defects in chromatin condensation and formation of apoptotic bodies 
in HeLa nuclei. In addition to a low percentage (15 ± 2%) of non-apoptotic nuclei, 
the great majority (75 ± 2%) of HeLa nuclei incubated in the caspase-6 apoptotic 
extracts appeared to be blocked in an early stage of chromatin condensation (stage II) 
after 2 h incubation and remained in this stage for up to 5 h (data not shown). The 
same effect was observed when a relatively selective inhibitor of caspase-6, z-VEID-
fmk, was added to wild type apoptotic extracts: 70 % of HeLa nuclei were blocked at 
a similar early stage of chromatin condensation (Fig 4.4A). Despite these changes in 
chromatin condensation, this experiment failed to detect any defect in 
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Figure 4.4 (continued) :Cell free system/DNA fragmentation in HeLa 
nuclei 
( -I- ) wt (+1-) (-I-) 
Et 
Fig 4.4: Isolated HeLa nuclei were incubated for 2 h in the apoptotic extracts 
previously characterized from wt, (+1-) and (-I-) cells (see Fig. 4.3) in the presence (~) 
or absence(-) of the caspase-6 specific inhibitor VEID-fmk at 1 ,uM. A, For each 
extract, the number of nuclei in apoptotic stages (I to IV) was determined. The stages 
were defined following DAR staining of HeLa nuclei incubated in etoposide-treated 
DT40 apoptotic extracts or control DT40 extracts. HeLa nuclei incubated in control 
extracts define stage I. After addition to apoptotic extracts, the chromatin begins to 
condense against the nuclear periphery and nucleoli (stage II). Next, the peripheral 
chromatin ring condenses into discrete masses that separate from one another while 
the condensed chromatin from the nucleolus migrates to the nuclear periphery (stage 
Ill). Finally, the chromatin masses form discrete apoptotic bodies and the nuclear 
shape is lost (stage IV). A nucleus representative of the major population is shown for 
each stage. Data shown represent three independent experiments with an average of 
300 nuclei counted per condition. After the 2 h incubation in the extracts, lamin A/C 
cleavage from HeLa nuclei was assessed by immunoblotting using the monoclonal 
antibody to human lam in A/C, JOL2. The cleavage products are shown by black dots. 
a-tubulin expression is used as a gel loading control. Controls in this experiment 
include extracts from untreated wild type cells, which gave 98% of uncondensed (non-
apoptotic) nuclei upon incubation. The low (2%) frequency of apoptotic nuclei seen in 
controls reflects apoptotic cells in the HeLa population used to prepare nuclei, as this 
low percentage is always observed even at early incubation times. B, Analysis of 
DNA fragmentation in the HeLa nuclei after a 2 h incubation in the extracts. 
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IV C3. Lamin A cleavage and DNA fragmentation 
Following a 2 hour incubation with cytosolic extracts from wild type and caspase-6' 
cells, HeLa nuclei were as also assessed for the state of lamin cleavage by 
immunoblot analysis using the JoL-2 monoclonal anti-human lamin A (Fig 4.4A). 
Lamin A cleavage product was present after incubation of the nuclei in cytosolic 
extracts with wild type and caspase-6 cells, but not following incubation of nuclei 
in the caspase-e extracts. 
These results strongly implied that caspase-6 is essential for the complete 
disassembly of HeLa cell nuclei in the in vitro apoptosis system. 
On the other hand, further investigations revealed that, unlike chromatin 
condensation, oligonucleosomal fragmentation of the DNA was not affected by the 
loss of caspase-6 (Fig 4.413). 
IV D. Apoptotic morphology of the nucleus and lamin 
cleavage in caspase-6 expressing caspase-6 cDNA 
IV Dl. Generating caspase-6':casp-6:EGFP stable cell line 
In order to confirm that the effects observed above were linked to the loss of caspase-
6 function, caspase-6 cells were transfected with caspase-6 cDNA. The caspase-6 
ORF was cloned into pEGFP-N1 vector, in which caspase-6:EGFP expression is 
under the control of a CMV promoter. Since caspase-6 cells (1126) were resistant to 
neomycin (see chapter III section III Dl), the pEGFP-N1 vector was modified by 
replacing its neomycin resistant cassette by a blasticidin resistance cassette. This 
construct was transfected into transfect caspase-6 cells and blasticidin-resistant 
clones were isolated. More than 12 clones were picked and the expression of 
exogenous caspase-6 was assayed by Northern and immunoblot analysis. One of 
these clones (RC6) showing a level of exogenous caspase-6 expression relatively 
close to wild type was selected for further study (Fig 4.5). 
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Figure 45: Trans fection of caspase-6-1- cells with caspase-6 cDNA 
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Fir 4.5: Analysis of the exogenous caspase-6 expression in one transfected 
clone RC6. Upper panels, mRNA expression analysed by Northern 
blotting; lower panels, protein expression analysed by immunoblotting using 
polyclonal anti-caspase-6 (19549). 
Figure 4.6: Analysis of nuclear morphology in a cell free system 







Fig 4.6: In vitro changes induced in HeLa nuclei induced after 2 h incubation 
with control and apoptotic extracts from wt, caspase-6 and caspase- 116  
cells 
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IV D2. Apoptosis analysis in the cell free system 
Apoptotic extracts were prepared from clone RC6 following induction of apoptosis 
by etoposide and assayed for the ability to induce apoptotic morphological changes in 
HeLa nuclei in vitro (Fig. 4.6). After 2 h incubation, nuclei in RC6 extracts showed a 
level of chromatin condensation similar to those incubated in the wild type extracts, 
whereas the chromatin condensation was still blocked in nuclei incubated with 
caspase-6 extracts. These results showed that the exogenous caspase-6 transfected 
into the caspase-6 clone totally reversed the nuclear disassembly defects due to 
caspase-6 deficiency. 
Results so far showed that caspase-6 is required for the completion of chromatin 
condensation and formation of apoptotic bodies in nuclei containing lamin A; on the 
other hand they do not answer the question of weather lamin A cleavage in critical 
for nuclear apoptosis. 
IV E. Lamin A cleavage and its implication in the apoptotic 
morphology of the nucleus 
IV El. Apoptotic morphology of Jurkat nuclei incubated in apoptotic 
extracts from wild type and caspase- extracts 
A final series of experiments was performed to determine whether the chromatin 
condensation defect observed in HeLa nuclei was due to the presence of uncleaved 
lamin A or to a requirement for caspase-6 action on some other substrate. As 
mentioned previously, Jurkat cells are a T lymphoma cell line, and therefore, do not 
express lamin A. As an initial step we compared the induction of apoptosis in vitro in 
Jurkat nuclei using extracts prepared from control or staurosporine-treated wild type 
and caspase-6 cells. As expected, after 2 h incubation in apoptotic extracts from 
wild type cells, Jurkat nuclei showed normal condensed chromatin and formation and 
the fragmentation of apoptotic nuclei. Strikingly, Jurkat nuclei incubated in caspase-
6 apoptotic extracts also showed essentially normal chromatin condensation and 
nuclear disassembly (Fig 4.7) similar to the apoptotic morphology of the nuclei of 
caspase-6 deficient DT40 cells (see Fig 4.1). 
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Fig 4.7: In vitro changes induced in Jurkat nuclei after 2 h incubation with 
control and apoptotic extracts from wild type and caspase-6 cells 
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These results indicated that a critical substrate of caspase-6 required for nuclear 
disassembly is not present in Jurkat cell nuclei, suggesting that this substrate could be 
lamin A. 
IV E2. Apoptotic analysis of Jurkat nuclei expressing GFP-Lamin A 
incubated in apoptotic extracts from wild type and caspase-e extracts 
IV E2a. Nuclear morphology 
To confirm the specific requirement for lamin A cleavage in apoptotic chromatin 
condensation and nuclear disassembly, Jurkat cells were stably transfected with a 
cDNA expressing GFP-lamin A (gift from Professor Larry Karnitz). This fusion 
protein showed the proper localization to the nuclear periphery. Jurkat nuclei 
expressing GFP-lamin A were then isolated and assayed, along with HeLa and 
normal Jurkat nuclei, for their ability to undergo chromatin condensation and nuclear 
disassembly in extracts from wild type and caspase-6 DT40 cells (Fig. 4.813). 
Interestingly, nuclei of Jurkat cells expressing GFP-lamin A behaved like HeLa 
nuclei in the extracts. They underwent normal disassembly accompanied by cleavage 
of GFP-lamin A in apoptotic extracts from wild type DT40 cells, but exhibited an 
early block in chromatin condensation and nuclear disassembly in the caspase-6 
extracts. Furthermore, the GFP-lamin A appeared to remain in a normal rim 
structure. 
IV E2b. Lamin A and Bi cleavage 
Similar to the HeLa assays described previously, after two hours of incubating Jurkat 
nuclei with the various extracts, lamin A cleavage was inspected by immunoblotting 
using the JoL-2 monoclonal anti-human lamin A (Fig 4.8C). As shown in Figure 
4.8C Jurkat nuclei ordinarily lack lamin A (lane 4-6). When GFP:lamin A was 
present (lanes 7-10), it was cleaved only in the wild type apoptotic extracts (lane 8) 
but not in the caspase-6 extracts (lane 9). As expected, both HeLa and Jurkat nuclei 
contain lamin B 1. This protein was completely cleaved in the wild type apoptotic 
extracts, but only partially cleaved in the caspase-6 extract. 
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Figure 4.8: Lamin A cleavage and its implications for nuclear 
apoptosis 
Control extracts 	Apoptotic extracts 
A 	Wt ( -I-)Wt( -I-) 








Fig 4.8: A, Isolated HeLa, Jurkat or Jurkat:GFP-Iamin A nuclei were 
incubated for 2 h in extracts from wt and caspase-6 cells treated with 1 pM 
staurosporine or diluent for 8 h. B, A nucleus representative of the major 
population is shown for each condition (DAPI) along with the GFP in the 
Jurkat.GFP-lamin A nuclei. The signal in the panel indicated by a white star 
was enhanced relative that in the other panels in order to see the residual 
GFP-lamin A fluorescence 
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Figure 4.8 (continued): Lamin A cleavage and its implications for 
nuclear apoptosis 
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Fig 4.8 : C, After the 2 h incubation in the extracts, the integrity of lamin A/C and 
Bi from HeLa nuclei was assessed by immunoblotting using the antibody to 
human lamin A/C (JOL2) and the antibody to lamin Bi (clone L-5). The 
cleavage products are indicated by black dots. Nonadjacent lanes on the same 
blot have been juxtaposed to compose each panel in this figure. The signal in 
lanes 7-10 was enhanced relative that in the other panels in orderto see the 
GFP-lamin A band. 
IV F. Discussion 
IV Fl. Role of caspase-6 during apoptotic execution 
Initial quests to discover the role of caspase-6 in cell death showed that the enzyme 
can cleave lamin A adjacent to the sequence VEID (Takahashi et al., 1996; Takahashi 
et al., 1997). The results presented above describe the characterisation of caspase-6 
deficient cells. This study revealed that in cells lacking lamin A (DT40 and Jurkat 
cell lines), caspase-6 seems to be dispensable for apoptotic execution in vivo and in 
vitro. Previous work showed that with the exception of lamin A, which appears to be 
the only caspase-6 specific substrate, all other caspase-6 substrates are also cleaved 
by other caspases. Surprisingly, apoptotic extracts from the caspase-6 cells showed 
a reduction in the level of DEVD-AFC cleavage activity, implying a decrease in the 
level of activation of caspase-3 -like enzymes. This suggests that caspase-6 in DT40 
cells might act upstream to activate caspase-3 as has already been shown in another 
system (Allsopp et al., 2000). To further study the role of caspase-6 in apoptotic 
execution we decided to investigate the effects of the loss of caspase-6 in cells that 
normally express lamin A 
IV F2. Role of caspase-6 in apoptotic chromatin condensation 
Our in vitro studies using the cell free system on isolated 1-Ida nuclei show that 
caspase-6 is required for chromatin condensation and proper dismantling of apoptotic 
nuclei in expressing lamin A. Yet, previous studies have yielded conflicting results 
concerning the role of caspase-6 in apoptotic chromatin condensation. The specific 
role of caspase-6 in chromatin condensation was stressed in one in vitro study when 
caspase-6 along with acinus were factors promoting apoptotic chromatin 
condensation in nuclei of permeabilized HeLa cells in the presence of active caspase-
3 (Sahara et al., 1999). In contrast, examination of nuclei isolated from apoptotic 
293T cells did not reveal any significant role for caspase-6 in the process (Slee et al., 
2001). This finding is not contradictory with our results since it is not clear whether 
293T cells express lamin A. 
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IV F3. Block in chromatin condensation and nuclear disassembly 
during apoptotic execution when lamin A is uncleaved 
The major conclusion drawn from the present study is that lamin A is cleaved only by 
caspase-6, as opposed to other substrates that could be cleaved by caspase-6 as well 
as other caspases. Additionally, these results also provide new information about the 
role of lamin A in nuclear structure. It is documented that expression of dominant 
negative mutants of lamin A can perturb DNA replication (Moir et al., 2000; Spann 
et al., 1997) and transcription (Lourim and Lin, 1992), and models in which lamin A 
has a role in organising the chromatin at the nuclear periphery have become popular. 
However, evidence supporting these models comes primarily from in vitro studies, 
and to date, no evidence has been obtained for a role of lamin A in organising the 
peripheral chromatin in intact nuclei. 
Published studies have suggested two possible mechanisms by which lamin A could 
have a role in organising the peripheral chromatin. A number of biochemical studies 
suggested that the tail and rod domains of lamins can bind directly to DNA, 
chromatin and core histones (Burke, 1990; Collard et al., 1990; Glass et al., 1993; 
Rzepecki et al., 1998; Taniura et al., 1995). More recent work has suggested that 
lamin A might make indirect interactions with the chromatin through a chain of 
interactions involving the LEM-family proteins ernerin and LAP 2 (Lin et al., 2000). 
Emerin and LAP 2 interact strongly with A-type lamins (Clements et al., 2000; 
Foisner and Gerace, 1993; Sakaki et al., 2001). Both emerin and LAP 2 bind a 
recently discovered protein called BAF (barrier to autointegration factor) through 
interactions with their LEM domains (Furukawa, 1999; Haraguchi et al., 2001; 
Shumaker et al., 2001). BAF is a highly conserved general dsDNA-binding protein 
that forms complexes in vitro containing multiple BAF subunits and multiple DNA 
molecules (Zheng et al., 2000a). Thus, it has been proposed that BAF may serve as a 
DNA bridging factor. Elimination of BAF by RNAi in C. elegans gives rise to 
chromosome segregation defects (Zheng et al., 2000a). BAF is also required for the 
proper targeting of Lamin A, ernerin and LAP2 to the nuclear envelope following 
mitosis (Haraguchi et al., 2001). Emerin binds to lamin A and BAF using distinct 
sites, and it has been proposed that a putative ternary complex of lamin A-emerin- 
BAF could serve to tether the chromatin at the nuclear periphery (Haraguchi et al., 
2001; Lee et al., 2001). 
To sum up, when lamin A is present, its cleavage is required for the completion of 
apoptotic chromatin condensation and apoptotic body formation. In the absence of 
lamin A cleavage, the chromatin collapses against the nuclear periphery, but it is 
unable to then fully condense further into membrane bound vesicles. This behaviour 
of the chromatin is consistent with it remaining tethered against the nuclear envelope, 
and suggests that one role of lamin cleavage in its rod domain during apoptosis may 
be to free the chromatin from the lamina. 
Therefore, lamin A cleavage appears to be essential for nuclear disassembly. Even 
when lamin B  is cleaved, the uncleaved lamin A maintains a peripheral structure 
that tethers the chromatin. This first evidence for lamin A-dependent tethering of the 
chromatin at the nuclear periphery supports recent proposals that this protein may 
have an important role in the establishment or maintenance of nuclear architecture. 
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Chapter V: Analysis of caspase-7DT40 cells 
VA. Introduction 
In parallel to the phenotypic analysis of caspase-6 deficient cell lines I started my 
main Ph.D. project which aimed for the elimination of the gene responsible for the 
production of caspase-7 in DT40 cells. As a whole, the caspase-7 knockout project 
followed the approach adopted to generate caspase-6 deficient DT40 cells. Again, 
the targeted disruption of the caspase-7 gene provided the tools necessary to study 
its particular role in the apoptotic process. 
The first reports on caspase-7 date back to 1995 when Fernandes-Alnemri et al., 
identified and characterized a CPP32/Mch2 homologue, Mch3, that was later named 
caspase-7 (Fernandes-Alnemri et al., 1995b). Caspase-7, like caspase-6, possesses a 
short prodomain and is most closely related to caspase-3, the best known player in 
apoptosis execution. Therefore, caspase-7 along with caspase-3 and —6, were 
classified as effector caspases. 
Caspase-7 plays an important role in nuclear apoptotic events. First, it was reported 
that caspase-7 is involved in the cleavage of ICAD thus, indirectly is involved in 
DNA fragmentation (Nagata, 2000). Secondly, it was proposed that caspase-7, in 
addition to caspase-3, is responsible for PARP cleavage (Germain et al., 1999). 
Caspase-7 was also reported to cleave focal adhesion kinase and kinectin, the 
receptor for the molecular motor kinesin which is involved in microtubule-based 
vesicle transport and membrane trafficking (Machleidt et al., 1998; Wen et al., 
1997). 
Despite all the studies on caspase-7, caspase-3 is still by far the most extensively 
studied effector caspase, and has been shown to cleave numerous cytoplasmic and 
nuclear proteins (Earnshaw et al., 1999; Faleiro et al., 1997; Fernandes-Alnemri et 
al., 1995a). It was initially claimed that caspase-3 is the major caspase activated in 
dying cells, and the enzyme was placed at the apex of the apoptotic execution 
pathway (Nicholson et al., 1995). However, subsequent studies placed caspase-6, a 
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second effector caspase upstream of caspase-3 in at least one experimental system 
(Allsopp et al., 2000). As discussed in chapter IV, we have found that when 
caspase-6 -1-  cells were exposed to etopo side, the overall level of caspase activation 
was substantially decreased, stressing the point that in the DT40 B lymphoma cell 
line caspase-3 might not be the most apical effector caspase. Therefore, the specific 
role of each caspase is apparantly more complicated than first expected and having 
successfully disrupted the caspase-7 gene in DT40 cells as described in chapter III 
we could now dissect its specific role. 
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V B. Phenotypic analysis of caspase-7 deficient DT40 cells 
V Bi. Proliferation rates 
First, proliferation rates of caspase- 	caspase- 7 " and caspase- 7 ':casp- 7:EGFP 
(see below) cells were compared. As shown in Figure 5.1 heterozygote, capase-7 
deficient cells and caspase-7:casp-7:EGFP cells proliferated at a rate similar to 
wild type DT40 cells. 
V 132. Resistance of caspase-7 deficient cells to apoptosis inducing 
drugs 
To examine whether deletion of the caspase- 7 gene affected the resistance of the 
cells to proapoptotic stimuli, cell viability assays (see chapter II section 11 15) were 
conducted after 24 h treatment using different doses of etoposide on wild type cells 
and two independent clones of both caspase- 7 and caspase- 7 -1- cells. Both 
caspase-7 deficient clones were 3.5 to 4.5 times more resistant to the drug than wild 
type cells. The IC50 for wild type, caspase-7 +1- and caspase-7 clones was 1.5, 5.2 
and 7.9 jtM, respectively (Fig. 5.2). Surprisingly, heterozygous clones showed a 
phenotype similar to the knockout cells. This resistance could explain the higher 
targeting efficiency obtained for the second allele if heterozygous cells were also 
more resistant to apoptosis during electroporation. On the other hand, it is possible it 
might be an outcome of clonal variability. Consequently, viability assays on two 
independent caspase-7 heterozygous clones were conducted. Results of these 
viability assays (Fig 5.2) showed that these two caspase-7 	clones behave 
similarly. This ruled out the possibility of clonal variability and confirmed that 
caspase-7 is haplo-insufficient. 
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Figure 5.1: Growth curves of wild type, caspase-7', 
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Fig 5.1: Growth curves of wild type, caspase-7, caspase-7 and 
caspase-7 1:caSP-7EGFP DT40 cells. Doubling time for the three cell lines 
was 8hat39°C. 
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Figure 5.2: Viability assays of wild type, caspase-7 1and 
caspase-7 -'- DT40 cells 
1 	 1 	 10 	 100 
Etoposide concentration (pM) 
Fig 5.2: Viability of different DT40 clones 24 h after incubation with 
increasing doses of etoposide. (a) and (b) represent two different clones for 
caspase-7 and caspase-7 cells. 
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In order to confirm that the drug resistance phenotype was a direct result of the 
caspase-7 gene deletion, caspaseTL  cells were transfected with a construct 
containing the chicken caspase-7 cDNA fused at its C-terminus to EGFP and under 
the control of a CMV promoter. Clones were isolated, and expression of the 
exogenous caspase-7 was visualized by fluorescence microscopy (Fig. 5.3). 
Cell viability assays were then performed by comparing caspase-7':casp-7:EGFP 
clones with wild type and caspase-7 cells (Fig. 5.4). Transfection with caspase-T" 
:casp-7:EGFP restored the wild-type sensitivity to the drug treatments. The rescue 
of the phenotype by expression of an exogenous caspase-7 in caspase-7 cells 
confirms that the drug-resistance phenotype results from the loss of caspase-7 
expression. 
V C. DNA fragmentation analysis 
V Ci. DNA ladder formation 
Since caspase-7 has been viewed as an effector caspase, terminal events in the 
apoptotic process in wild type and caspase- T" cells were examined. At various 
times after treatment with etoposide, cellular DNA was extracted and assessed for 
internucleosomal cleavage (Fig. 5.5A), a classical feature of apoptotic execution 
(Wyllie, 1980). The onset of DNA fragmentation was delayed approximately 2 h 
after the addition of etoposide in two different knockout clones relative to wild type 
cells. This delay was no longer visible by 3 h after the addition of etoposide. 
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Figure 5.3: Caspase-7':casp-7:EGFP cell line 
Fig 5.3: ImmunofluorescenCe of stable caspase-7. casp-7:EGFP 
expressing cell lines. Caspase-7, cells were transfected with caspase-
7:EGFPN-1 (Invitrogen). Four neomycin resistant clones expressing 
caspase-7-EGFP with different levels are represented. (A)chromatin stained 
with DAPI. (B) caspase-7-:EGFP. (C) Merged pictures. 
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Fig 5.4: Viability assays of caspase-7, caspase7:caSP-7EGFP clones 
and wild type cells 24 h after incubation with increasing doses of etoposide. 
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gene, as expression of the caspase-7:EGFP fusion protein in the caspase-T' cells 
largely eliminated the delay (Fig. 5.513). 
Previously it has been shown that it is the CAD/DFF40/CPAN nuclease (Enari et al., 
1998; Halenbeck et al., 1998; Liu et al., 1997) and not endonuclease G (Li et al., 
2001; Parrish et al., 2001) that is responsible for oligonucleosomal DNA 
fragmentation during etoposide-mediated apoptosis of DT40 cells (Samejima et al., 
2001). Consequently, the observed delay in the nucleosomal DNA fragmentation 
process strongly suggests a direct or indirect involvement of caspase-7 in the 
cleavage of ICAD, yet caspase-7 fails to cleave ICAD (Meliroy et al., 2001). 
V D. Substrate cleavage 
As stated previously in the introduction to this chapter, caspase-7 cleaves several 
substrates during apoptotic execution. However, it has been argued that it is caspase-
3 and not caspase-7 which cleaves PARP and the lamins in vivo, since in apoptotic 
Jurkat cells, active caspase-7 localised only to the mitochondrial and microsomal 
fractions, however caspase-3 could be detected in the nuclear fraction (Zhivotovsky 
et al., 1999). Therefore, the kinetics of cleavage of lamin BI, B2 and PARP, in 
caspase- 7/ and wild type cells were compared. 
VD1. Lamin Bl and B2cleavage 
Results of lamin BI and B2 cleavage showed that caspase-7 is required for the 
normal kinetics and extent of lamin BI and B2 cleavage in DT40 cells (Fig 5.6). In 
wild type cells, both lamins were totally cleaved after 3 h of 10 iM etoposide 
treatment. However, in the caspase- 7 cells, lamin B 1 was partially cleaved after 3 
h and lamin B2 cleavage began only after 4 h. For both lamins, an uncleaved pool 
remained for as long as 5 h. These results could reflect either a direct involvement of 
caspase-7 in lamin cleavage, or they could be a result of delayed activation of other 
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Fig 5.5: A, DNA nucleosomal 
laddering analysis during an 
etoposide time course on wild type 
cells and two different caspase-7 
clones. B, Quantitative analysis of 
DNA fragmentation by Tunel 
staining measured by flow 
cytometry. Comparison of wild-type, 
caspase-7 and caspase-7.tasP 
7:EGFP cells following exposure to 
10 pM etoposide for varying lengths 
of time. Data shown represent three 
independent experiments. For each 
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Fig 5.6: Analysis of lamin Bi and B2 cleavage kinetics by immunoblotting 
of cell lysates from wild-type and caspase-7 cells treated with 10 PM 
etoposide for up to 5 h, using monoclonal antibodies to chicken lamin B1 
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In the former case, one would expect that the slower cleavage might be a result of 
sub-optimal recognition of the binding site by a redundant caspase, such as caspase-
3, that might recognize the binding site with lower affinity. In the latter case, it 
would be expected that once the downstream caspase were activated, the cleavage 
would proceed with normal kinetics. 
V D2. PARP cleavage 
To distinguish between these two models, the cell-free system was used to examine 
the cleavage of PARP, a classical substrate of both caspases —3 and —7 in vitro 
(Fernandes-Alnemri et al., 1995a; Kaufmann et al., 1993; Salvesen and Dixit, 1997). 
PARP cleavage typically takes place before lamin cleavage (Lazebnik et al., 1993; 
Zhivotovsky et al., 1999). Unfortunately, none of antibodies tested recognized 
chicken PARP. Therefore ,we employed the cell-free system in which HeLa nuclei 
were induced to undergo apoptotic biochemical changes in extracts prepared from 
apoptotic wild type and caspaseT" DT40 cells (as described in material and methods 
section II E2). 
HeLa nuclei were added to cytosolic extracts prepared from wild-type and caspase-
7' DT40 cells following exposure to etoposide for 1, 3 and 6 hours, these will be 
referred to as 1 h, 3 h and 6 h extracts. Following a 3-hour incubation at 37°C, 
PARP cleavage was assessed by immunoblotting (Fig. 5.7). When HeLa nuclei were 
incubated with lh-extracts from wild-type cells, the majority of PARP was cleaved. 
Cleavage was complete in the 3h-extracts and 6h-extracts. In contrast, when HeLa 
nuclei were incubated in lh-extracts from caspase7 cells, only a small fraction of 
PARP was cleaved, and some uncleaved 116 kDa protein could still be seen 
following the incubation in 3h-extract from caspase7 cells. PARP cleavage was 
complete following incubation of the HeLa nuclei in 6h-extract from caspase 7 
cells. 
Genetic analysis of caspase6 and -7 function in vertebrate D140 cell line 
.11 
Figure 5.7: PARP cleavage kinetics in apoptotic WT and 
caspase-7 DT40 cells 
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Fig 5.7: Cleavage kinetics of PARP following incubation of HeLa nuclei with 
extracts prepared from etoposide-treated wild-type and caspase- 7' cells. 
PARP cleavage was assessed by immunoblotting with a polyclonal antibody 
(Cell Signalling, 9542), 
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V E. Loss of plasma membrane asymmetry during apoptotic 
execution in Caspase-7 deficient cells 
One of the hallmarks, and considered an early marker, of apoptosis is the loss of 
plasma membrane asymmetry which can be assessed by the externalisation of 
phosphatidylserine. In the presence of Ca Annexin V binds to phosphatidylserine, 
which is usually restricted to the inner leaflet of the plasma membrane, but which 
becomes randomly distributed early in apoptotic execution (Koopman et al., 1994). 
Although some studies have suggested that this occurs in a caspase-dependent 
manner (Martin et al., 1996; Vanags et al., 1996; Frasch et al., 2000) others have 
raised the possibility that the event can be independent of caspase activation 
(Ferraro-Peyret et al., 2002). The involvement of caspase-7 in this event was 
assessed by measuring Annexin V labeling after addition of etoposide or 
staurosporine to the culture. After 3 h 15 mins of etoposide induction, 50% of the 
wild type cells were annexin V-positive whilst knockout cells reached this level only 
after 5 h of etoposide treatment (Fig. 5.8A) 1 . This delay in membrane reorganisation 
was confirmed to result from loss of caspase-7 expression. The expression of 
exogenous caspase-7 rescued the phenotype, and caspase-7 ":casp-7:EGFP cells 
expressed surface phosphatidylserine with kinetics similar to wild type cells. 
Analogous results were obtained when the same experiment was repeated using 
staurosporine to induce cell death (Fig. 5.813). However, in this latter assay, where 
the overall kinetics of phosphatidylserine exposure were substantially delayed, the 
expression of an exogenous caspase-7 in the knockout cells gave only a partial 
rescue of the phenotype, suggesting that the caspase-7:EGFP fusion protein may not 
be fully functional. 
'P1 staining was conducted, as recommended, to discriminate between apoptotic and necrotic cells. However, we 
were unable to get any significant results for the P1 staining by FACS analysis. Therefore, for each time point, prior 
to collecting cells for annexin V staining,FACS analysis, cells were carefully examined under the microscope. We 
are confident that the annexin V positive cells, after etoposide and staurosporine treatment, were apoptotic and not 
necrotic DT40 cells. 
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Fig 5.8: Quantitative analysis of phosphatidylserine exposure at the 
cytoplasmic membrane by annexin V staining measured by flow cytometry. 
Data shown represent three independent experiments. For each sample, 
15,000 cells were counted. Wild-type, caspase-7 and caspase-7:casp-
7:EGFP cells were compared following exposure to : A, etoposide at 10 PM 
for up to 6 hours; B, staurosporine at 1 pM for up to 9 hours. 
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V F. Caspase activation in caspase-7 deficient cells 
To better understand the reasons behind the delays in apoptosis observed in the 
analysis of caspase-7 deficient cells and to further assess the possibility that caspase-
7 deficiency results in altered activation of other apoptotic caspases, cytosolic 
extracts (see Chapter II section II E2) were prepared from wild-type, caspase-T" 
and caspase-7':casp-7:EGFP DT40 cells at varying times following addition of 10 
tIM etoposide. 
Caspase activity was first assayed in extracts prepared 3 and 6 hours after addition 
of etoposide (Fig. 5.9). These two time points were used because, when checked 
using the inverted phase contrast microscope, DT40 cells started displaying an 
apoptotic morphology not earlier than 3 hours after etoposide addition. 
Extracts were characterised in terms of overall caspase activation, and also for 
specific caspase activity. Broad spectrum labelling of caspases using zEK(bio)D-
aomk showed the activation of several caspase species in these extracts, with a 
major labelled band appearing at 20 kDa (Fig. 5.9A). 
Wild type and caspase-7 ' cells exhibited no significant differences in caspase 
labelling after induction of apoptosis. In an independent approach, caspase-6, -3/7, 
and —9 -like activities were assessed in these extracts by measuring VEID-AFC, 
DEVD-AFC and LEHD-AFC cleavage respectively, in the laboratories of Professor 
Scott Kaufmann, Rochester, USA (Fig. 5.913). Again, no significant differences 
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Figure 5.9: Caspase affinity assays and caspase labelling 
assays after 3 and 6 hours of 10pM etoposide treatment 
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Fig 5.9: Measurement of caspase 
activity in cytosolic extracts from wild-
type and caspase-7 cells following 
exposure to etoposide for 3 and 6 
hours. A, Labeling of active caspases 
by zEK(bio)D-aomk and separation on 
SDS-PAGE. Endogenous biotinylated 
protein expression was used as gel 
loading control. B, Measurement of 
DEVD-AFC, VEID-AFC and LEHD-
AFC cleavage activity in cytosol from 
10 pM etoposide-treated wild-type 
and caspase-7 DT40 cells 
WT Caspase-7 
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Upon closer inspection, a slight decrease of about 15% was observed for the DEVD-
AFC cleavage activity in the caspase-7 cells when compared to the wild type. We 
hypothesised that this might be the result of a delay in caspase activation occurring 
earlier than 3 h in caspase-7 ' cells. Therefore, caspase activity and caspase 
labelling assays using apoptotic extracts from cells treated for 30 min or 1 hour with 
10 !tM  etoposide were repeated. Interestingly, both the caspase labelling and 
activity assays showed clearly that caspase activation was delayed in caspase-7 
deficient cells (Fig. 5. 10). In wild type cells, caspases were activated after one hour 
of etoposide treatment, whereas no detectable caspase activity was observed in 
caspase-7 deficient cells (Fig. 5.1 OA). Quantitative assays of caspase-6, -3/7, and - 
9-like activity confirmed this result. One hour after apoptosis induction with 10 !tM 
etoposide, VEJD-AFC, DEVD-AFC and LEHD-AFC cleavage was readily detected 
in wild type apoptotic extracts, but this was almost totally absent in caspase-7 
extracts (Fig. 5.1OB). 
These results provide strong evidence for an upstream role for caspase-7 in 
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Figure 5.10: Caspase affinity assays and caspase labelling 
assays after 30 minand 1 hour of 10pM etoposide treatment 
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Fig 5.10: Measurement of caspase 
activity in cytosolic extracts from wild-
type and caspase-7 1- cells following 
exposure to etoposide for 30 min and 1 
hour. A, Labeling of active caspases 
by zEK(bio)D-aomk and separation on 
S DS- PAGE. Endogenous biotinylated 
protein expression was used as gel 
loading control. B, Measurement of 
DEVD-AFC, VEID-AFC and LEHD-
AFC cleavage activity in cytosol from 
10 pM etoposide-treated wild-type and 
caspase-7 DT40 cells 
Time (h) 
	
0 0.5 1 	0 0.5 1 
WT 	Caspase-7 
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V G. Discussion 
Many research groups believe that caspase-3 is the main executor caspase 
responsible for almost all aspects of apoptotic morphology, and that it is even 
required for caspase-6 and —7 activation (Bratton et al., 2000; Wolf et al., 1997). 
Alternatively, a variety of studies have raised the possibility that caspase-3 and 
caspase-7 might have redundant roles. This view is based on the similar ability of 
these two enzymes to cleave tetrapeptide-based synthetic substrates (Fernandes-
Alnemri et al., 1996; Fernandes-Alnemri et al., 1995a; Talanian et al., 1997) and on 
the ability of caspase-9 to activate caspases-3 and —7 directly (Slee et al., 2001; 
Srinivasula et al., 1997). On the other hand, differences in the abilities of caspases-3 
and —7 to cleave polypeptide substrates have been extensively described (Ghayur et 
al., 1996; Kottke et al., 2002; Lane et al., 2001; Mcllroy et al., 1999; Slee et al., 
2001). Moreover, caspase-3 gene deletion results in viable mice that have 
neurological defects in some genetic backgrounds, whereas caspase- 7 gene deletion 
reportedly is lethal in mice (Zheng et al., 1999; Zheng et al., 2000b). These results 
raise the possibility that caspase-3 and caspase-7 have separate and distinct functions 
in a cellular context. 
Results presented in this study show that caspase- 7 functions early in the apoptotic 
pathway induced by drugs such as etoposide and staurosporine. Because caspase-7 
deficiency results in a delay in activation of caspase-3, caspase-6 and caspase-9, the 
results described above place caspase-7 upstream of these executioner caspases 
during apoptosis. 
V Gi. Caspase-7 is required for timely execution of apoptosis in DT40 
cells 
The characterisation of caspase-7 deficient cells revealed a clear delay in DNA 
fragmentation as concluded from DNA ladder formation and quantitative analysis of 
DNA fragmentation by Tune! staining. Almost certainly these results reflect a delay 
in the activation of DFF40/CAD/CPAN following cleavage of DFF45/ICAD, as it 
has been shown previously that endonuclease G has no significant role in apoptotic 
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DNA fragmentation in DT40 cells (Samejima et al., 2001). Moreover, the widely 
accepted conviction is that caspase-7, with a short prodomain, is an effector caspase 
activated downstream the apoptosis cascade with a role in the later stages of 
apoptotic execution. However, this belief has been challenged by the experiments 
presented here since deficient cells showed that the enzyme functions early in the 
apoptotic pathways induced by drugs such as etoposide and staurosporine, possibly 
even prior to the commitment of cells to death. 
Caspase-7 deficient cells show not only a delay in loss of plasma membrane 
asymmetry, but were also more resistant to the common apoptosis inducing drugs. In 
more detail, the requirement for caspase-7 in the initiation of the apoptotic process 
was evident in the phophatidylserine (PS) redistribution after apoptosis induction, an 
early marker of apoptosis (Koopman et al., 1994). Published evidence has disagreed 
over whether caspases are (Martin et al., 1996), or are not (Ferraro-Peyret et al., 
2002) required for phosphatidylserine exposure. Annexin V staining of caspase-7 
deficient cells showed a delay of at least 90 min after 10 mM etoposide or 1 jiM 
staurosporine treatment. 
Further evidence for an important role of caspase-7 in the coordination of cell death 
came from the viability assays conducted. After 24 hours of etoposide treatment, at 
least 50% of the population of caspase-T cells was still viable at drug 
concentrations where >90% of wild type cells and cells expressing a caspase-T 
:casp-7:EGFP construct were dead. Caspase-7 and caspase-7 cells also seemed 
to survive the process of electroporation and cloning better than their wild-type 
counterparts. 
Surprisingly, caspase-7 cells showed the same phenotype as caspase-T' cells in 
all assays. This could be explained if caspase-7 locus is haplo-insufficient (NK & 
SR, unpublished data). Alternatively, one allele of the caspase-7 gene in DT40 cells 
may be hypermethylated, as gene imprinting has been demonstrated in chicken 
(McQueen et al., 2001). This is less likely, as several independently obtained 
heterozygotes gave identical phenotypes. However, we cannot exclude the additional 
possibility that targeting of the two alleles might not be random. 
Importantly, all phenotypes observed in caspase-7 and caspase-T cells were 
reversed upon transfection with a cDNA encoding chicken caspase-7 fused to EGFP. 
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In addition, further support to the requirement of caspase-7 for the timely execution 
of late apoptotic process came form analysis of substrate cleavage lamin B I and B2. 
These results clearly demonstrate that caspase-7 is required for the timely execution 
of this important stage of the apoptotic pathway. 
The observed delays could be due to slower rates of cleavage by a caspase with a 
lower affinity for each substrate if, for example, this cleavage were normally 
executed by caspase-7. To assess this possibility, nuclei were exposed to cytosolic 
extracts prepared from wild-type and caspase-T - cells following exposure to 
etoposide for 3 h, at which time the caspase cascade appeared to be equally active in 
both cell types. If caspase-7 were particularly effective at cleaving substrates, we 
would have observed diminished cleavage in caspase-7-deficient extracts in this 
experiment. Although previous findings have indirectly implicated caspase-7 in 
PARP cleavage (Germain et al., 1999; Woo et al., 1998) our observations revealed 
no difference in PARP cleavage in the 3 h extracts. These results support and 
extend a previous study in which caspase-7 was immunodepleted from Jurkat 
extracts (Slee et al., 2001). Results of both studies argue against the possibility that 
caspase-7 is required for particular apoptotic substrate cleavages. Instead, our 
further experiments suggest that the delayed cleavage of substrates and CAD 
activation observed in caspase-7 cells reflect an overall delay in activation of the 
executioner caspases. 
V G2. Caspase-7 is required for early events of apoptosis in DT40 cells 
Examination of the kinetics of caspase activation revealed a delay in activation of 
caspases-3 and —6 in caspase-T cells. This delay was evident when active caspases 
were analyzed by affinity labeling and also when individual caspase activities were 
assayed using tetrapeptide-based substrates. In particular, activities that cleave 
DEVD-AFC, VEID-AFC and LEHD-AFC, classical substrates for caspases-3, -6 
and —9, were all elevated in < 1 h in parental cells but not caspase- T cells. The 
delay in activation of caspases-3 and —6 clearly places caspase-7 upstream of the 
abundant executioner caspases; and the delay in detection of caspase-9-like activity 
might seem to place caspase-7 upstream of caspase-9 activation as well. Consistent 
with this possibility, Marsden et al. recently suggested that active caspase-7 can be 
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detected by affinity labeling as Apaf- 1-deficient cells, which lack the ability to 
activate caspase-9, undergo apoptosis (Marsden et al., 2002). On the other hand, the 
fact that the level of active caspases in caspase- 7 cell extracts ultimately reached 
that in wild type cell extracts, reveals that a slower alternative mechanism of caspase 
activation remains intact in these cells. 
V G3. An emerging view of caspase-7 function in apoptosis 
A combination of direct experimental evidence and primary structure analysis has 
led to the view that there are two classes of caspases. Initiator caspases contain long 
prodomains with protein-protein interaction motifs that are responsible for targeting 
them to scaffolding complexes where induced proximity enables the weakly active 
zymogens to auto- and trans-activate (Earnshaw et al., 1999). Effector caspases lack 
extended prodomains, and have been thought to be activated en masse by the 
initiator caspases. The experiments described above show that caspase-7 may 
function much closer to the apex of the cascade than implied by this dogma. 
The results presented above suggest that caspase-7 is activated before caspase-3, and 
may even be involved in caspase-3 activation in DT40 cells. Several other research 
groups have also documented similar observations. Studies of the death of MOLT-
4, human leukemia cells, following exposure to ionizing radiation suggested that 
caspase-7 is activated prior to caspase-3 (Coelho et al., 2000), and after B cell 
receptor crosslinking, B lymphocytes activate selectively caspase-7. Likewise, 
caspase-7 (but not caspase-3) has been implicated in the cleavage of caspase-12 
during endoplasmic reticulum stress (Rao et al., 2001) and in cell death occurring in 
the absence of Apaf- 1 and caspase-9 activation (Marsden et al., 2002). Finally, a 
form of the caspase cascade has recently been proposed in which the down-
regulation of the anti-apoptotic protein Bcl-2 leads to initiator caspase activation 
followed by a selective activation of caspase-7 and dismantling of the cell (Le et al., 
2001). 
The overall picture from the analysis of caspase-7 deficient cells strongly suggests 
that caspase-7 is involved earlier than other effector caspases in the apoptotic 
execution process in DT40 cells. However, more experiments need to be conducted 
to confirm that caspase-7 is indeed activated prior to any 'conventional' initiator 
122 
Genetic analysis of caspase-6 and -7 function in vertebrate DT40 cell line 
caspase in DT40 cells. For instance, the caspase-7":Casp-7:EGFP cell line could be 
used to assess the kinetics of caspase-7 cleavage. A time course experiment could be 
conducted using varied apoptosis inducing drugs, such as etoposide or staurosporine, 
and the activation of caspase-7 could assessed by monitorin by western analysis, 
using an anti-GFP antibody. In parallel apoptotic extracts would be prepared form 
the same samples and the activation of initiator caspases (caspase-2, -8 and -9) 
would be assessed by activity assays and compared to the timing of caspase-7 
activation. 
The results of the experiments explained above could provide more proof to our 
belief that caspase-7 role in DT40 cells is rather an 'initiator caspase' contrary what 
has been thought. We hypothesis that DT40 cells may have two sequential pathways 
leading to caspase activation in response to etoposide and staurosporine treatment. 
The first pathway leads to the activation of caspase-7, and this leads to activation of 
the other caspases. In the absence of caspase-7, the second pathway is eventually 
activated, with a 1-2 hour delay in the amplification of the caspase cascade (Fig 
5.11). 
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Figure 5.11: Proposed model for caspase-7 activation 







Fig 5. 10. Proposed model, DT40 cells may have two sequential pathways 
leading to caspase activation. In the first pathway (1 ,left) caspase-7 is the 
most apical effector caspase capable of apoptotic execution dependently or 
independently of downstream capases it activates. The second pathway (2, 
right) is the conventional caspase signalling cascade. Pathway 1 is the first 
to be activated in normal apoptotic cells. In the absence of caspase-7, the 
second pathway is eventually activated, with a 1- to 2-hour delay in the 
amplification of the caspase cascade. Further studies are required to 
determine the presence and relative importance of these two pathways in 
other cell types. 
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Chapter VI: Conclusions and future directions 
VI A. Aim of this thesis 
The aim of this thesis was to seek a deeper understanding of specific caspase-6 and 
caspase-7 functions in apoptotic execution. The particular contributions, of each of 
these two enzymes, to apoptotic cell death had not been fully characterized. A gene 
knockout approach, in the DT40 cell line, was adopted to elucidate the role played by 
caspase-6 and caspase-7 in apoptotic cell death. 
VI B. Conlusions 
VI Bi. Generation of caspase-64 and caspase-7" DT40 cell lines 
To investigate the roles of caspase-6 and caspase-7 in apoptosis, the aim was to 
generate null DT40 cell lines. The two projects were conducted independently, 
however the strategies adopted were similar. Chicken DT40 genomic lambda Fixil 
library was screened using parts of caspase-6 and caspase-7 chicken eDNA as 
probes. Several phages were isolated and one phage was chosen for each caspase and 
sent for sequencing. Targeting vectors, for the caspase in question, were generated 
and transfected into DT40 cells. Using Southern blot analysis as a screening strategy 
to identify proper targeting events, caspase-6 and caspase-7 deficient DT40 cells 
were isolated. The loss of caspase-6 expression was confirmed by Northern and 
Western blot analysis. However, unexpectedly, when Northern blot assays and RT-
PCR experiments were conducted to verify the loss of caspase-7 mRNA in caspase-7 
targeted cells, they failed to detect caspase-7 mRNA in wild type cells. The most 
probable explanation is that caspase-7 expression in DT40 cells is very low. 
Consequently, in order to confirm that the conclusions drawn from analysis of 
caspase- T'- cells are indeed a result of the loss of this enzyme, caspase-7 deficient 
cells expressing caspase-7 fused to EGFP were used as controls in subsequent 
experiments. 
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VI B2. Analysis of Caspase-6 deficient DT40 cells 
The first assays conducted were to examine and compare apoptosis of caspase-6 
cells to wild type DT40 cells. However, when apoptosis was induced, no difference 
between wild type and caspase-6 deficient cells was noted in any of the apoptotic 
processes investigated (see chapter IV). Further characterisation of DT40 cells 
revealed that the B lymphoma cell line does not express lamin A. As discussed in 
the Introduction to this thesis and in further details in chapter IV, caspase-6 is 
reported to cleave lamin A specifically (Lazebnik et al., 1995b; Takahashi et al., 
1996). Therefore, the next step of analysis was to assess the role of caspase-6 in 
apoptotic execution in cells that express lamin A, such as HeLa cells. An in vitro 
approach was adopted where cytosolic extracts were prepared from non-apoptotic 
and apoptotic caspase-6± and wild type cells and subsequently incubated with 
isolated HeLa nuclei. The results of this assay showed that lamin A cleavage and 
chromatin condensation were blocked when HeLa nuclei were incubated with 
caspase-6 cytosolic extracts, whereas nuclei were properly dismantled when 
incubated with wild type apoptotic extracts. Therefore, the first conclusion drawn 
was that caspase-6 is required for completion of chromatin condensation and 
formation of apoptotic bodies in nuclei containing lamin A. Logically, the next 
question asked was "is lamin A cleavage required for chromatin condensation and 
nuclear disassembly?" To answer this query Jurkat cells expressing a GFP-lamin A 
were used. 
Jurkat cells (a human T lymphoma cell line), like DT40 cells, do not express lamin A 
and, therefore apoptosis proceeded normally when caspase-6 apoptotic extracts 
were incubated with isolated Jurkat nuclei. However, when Jurkat nuclei expressing 
GFP-lamin A were used, lamin A cleavage and chromatin condensation were 
blocked. These results showed that, when cells express lamin A, it must be cleaved 
in order for nuclear apoptosis to go to completion. 
To sum up, characterisation of deficient cells indicates that caspase-6 is dispensable 
for the induction of apoptosis, but is required for the completion of chromatin 
condensation and formation of apoptotic bodies when nuclei express lamin A. 
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VI B3. Analysis of Caspase-7 deficient DT40 cells 
To investigate the impact of lack of caspase-7 in DT40 cells, viability assays were 
conducted using the apoptosis-inducing drugs etoposide and staurosporine. The 
results of these experiments showed that caspase- T1 _ cells are more resistant to 
apoptosis. Further examination of the apoptotic process by annexin V staining, to 
assess the loss of plasma membrane integrity, and Tunel staining and DNA laddering, 
to inquire about DNA fragmentation, revealed that caspase- T cells are delayed by at 
least 90 min in all aspects of apoptotic execution investigated. In addition, lamin 131, 
B2 and PARP cleavage were delayed in caspase- 7 /- cells. These results showed that 
caspase-7 is required for timely execution of apoptosis in DT40 cells. Surprisingly, 
caspase-7 cells showed the same phenotype as caspase-T cells in all assays 
conducted and using several heterozygous clones to rule out the possibility of clonal 
viability. This result could be explained if caspase-7, which is expressed at 
extremely low levels in DT40 cells, is haplo-insufficient. The fact that caspase-7 and 
its mRNA could not be detected in wild type DT40 cells and that all phenotypes 
observed in caspase- 7 and caspase- T cells were reversed upon transfection with a 
cDNA encoding chicken caspase-7 fused to EGFP suggest that caspase-7 might well 
be haplo-insufficient in DT40 cells. Finally, to assess the possibility that the 
observed apoptotic delay in caspase-71-  cells is a result of altered activation of other 
apoptotic caspases, caspase affinity labelling and caspase activity assays performed. 
The results of these assays showed that deficient cells exhibit a delay in caspase 
activation when compared to wild type DT40 cells, providing an explanation for the 
differences in apoptotic execution between caspase-7 null and wild type DT40 cells. 
In conclusion, the inability of any other caspase to substitute for the loss of caspase-7 
underlines its non-redundant function and even implies that caspase-7 is rate limiting 
for the early stages of apoptosis. The results presented in this study strongly suggest 
that caspase-7 is involved earlier than other effector caspases in apoptotic execution. 
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VI C. Future directions 
VI Cl. A non-apoptotic role for Caspase-6 
Initial gene targeting experiments suggested strongly that caspase-6 is an essential 
gene. The first allele targeting of the caspase-6 gene occurred with a frequency of 8 
%. When the same knockout construct (with a different selectable marker) was 
introduced into the heterozygotes, no homologous recombinants were obtained 
among the 306 clones screened (all had acquired the second drug resistance marker). 
Remarkably, when the same experiment was performed in the absence of selection 
for the first marker, specific gene targeting was obtained in 16 % of the clones. In 
this case, all recombinants had re-targeted the first allele. When heterozygotes were 
transfected with cDNAs expressing caspase-6 or caspase-6: EGFP, the homologous 
targeting efficiency was 4% as expected. Normally, these data would be taken as 
rigorous evidence that caspase-6 is an essential gene, however, one of the caspase-6 
deficient clones isolated (clone 1126) that initially expressed caspase-6, apparently 
later lost the exogenous sequences. This clone was confirmed to be caspase-6 null by 
Southern, Northern and Immunoblotting, as well as caspase-6 activity assay but 
grows normally, confirming conclusively that caspase-6 is not essential for life. 
Therefore, the next step in the analysis of caspase-6 function would be to explore the 
interesting possibility that this enzyme may be essential either for homologous 
recombination or for some other aspect of the growth of DT40 cells under the 
conditions used to obtain homologous recombinants. To test this hypothesis, 
caspase-6 and wild type DT40 cells will be transfected with the ovalbumin 
replacement vectors (generous gift of Dr Takeda, Japan). It has been shown 
previously that these vectors have a remarkable 90% efficiency for proper integration 
when transfected to DT40 cells (Buerstedde and Takeda, 1991). Therefore, a 
comparison of ovalbumin targeting efficiency between caspase-6 cells and wild 
type DT40 cells might reveal a role for caspase-6 in homologous recombination. 
VI C2. Caspase-7 and alternative signalling cascades during apoptotic 
execution 
Studies of clonal deletion of autoreactive B cells by BCR (B Cell Receptor) cross-
linking suggest that caspase-7 is a key player of this process (Nitta et al., 2001). 1gM 
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treatment of immature B lymphocytes causes growth arrest and caspase-7 activation 
independently of caspase-8 and cytochrome c release (Ruiz-Vela et al., 1999). In 
addition, BCR cross-linking induces the selective activation of the effector caspase-
7, but not of caspase-3 (Bras et al., 1999). DT40 cells are ideal for the study of 
apoptosis induced by BCR cross-linking. Ironically, clone 18, the wild type DT40 
clone used in the generation of caspase-7 deficient cells, was selected as an IgM 
clone, and therefore, the apoptotic pathway in clone 18 could not be induced through 
the BCR pathway. However, after several rounds of cell passages, IgM could revert 
and re-express their absent surface 1gM (Buerstedde et al., 1990). It will be 
challenging to establish the optimal conditions, if possible, for clone 18 apoptotic 
response to anti-IgM application and consequently assess the effect of BCR 
crosslinking in caspase- T cells. 
Likewise, caspase-7 (but not caspase-3) has been implicated in the cleavage of 
caspase-12 during endoplasmic reticulum (ER) stress. Therefore, caspase-7 deficient 
DT40 cells could be subjected to ER stress-inducing agents and apoptotic extracts 
would be prepared to assess for caspase activation and evaluate the role of the ER 
and more specifically, to comprehend the status of caspase-7 in this novel signalling 
cascade. 
In addition to surface 1gM engagement and the ER's role in apoptosis, it would be 
interesting to assay for a role of caspase-7 in conventional receptor mediated 
apoptosis cascades. Unfortunately, tools available for chicken systems are limited 
and human FasL or TNF are reported to be functional in chicken cell lines. 
Nevertheless, available ligands could be tested since it is important to query whether 
caspase-7 activation precedes caspase-8 activation in the receptor mediated pathway 
redefining the role of caspase-7, in particular the classification of effector caspases 
as proteins with short prodomains. 
VI C3. A non apoptotic role for caspase-7 
As discussed, caspase-6 may play a role in recombination (see above). Strikingly, 
similar but opposite to caspase-6, caspase-7 gene replacement did not follow the 
predicted mathematical rules which predicts that the efficiency of targeting for the 
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second allele should be half that of the first. The targeting efficiency for the first 
allele was 1.4% for both knockout constructs used (chapter III). We predicted a 0.7% 
efficiency for the second allele, consequently more than 200 clones were screened 
for second allele replacement. Surprisingly, the second allele targeting was 10% and 
many independent caspase-7 deficient clones were isolated. The most possible 
explanation for this high targeting efficiency is, if caspase-7 is haplo-insufficient in 
DT40 cells, caspase-7 are more resistant to cell death than wild type DT40 cells 
and therefore can better withstand electroporation procedure. 
However it was interesting and unforeseen to have opposite results for caspase-6 and 
caspase-7 gene targeting and it would be challenging to investigate whether caspase-
7 has any role in homologous recombination. Consequently, replacement vectors 
with low targeting efficiency could be transfected into caspase-T' and wild type 
DT40 cells to compare the ratios of proper integration between caspase-7 deficient 
and normal DT40 cells. 
VI D. Final remarks 
In addition, caspase-7 deficient cells could be used for subsequent biochemical 
assays to elucidate the functions of different domains or the effects of modifications 
on the enzyme function, for example to study the importance of caspase-7 
phosphorylation and its impact on caspase-7 activation in the apoptotic process. 
Initial experiment conducted in the Earnshaw and Kaufmann laboratory showed that 
human caspase-7 is a phosphoprotein. Therefore, when the caspase-7 
phosphorylation site is mapped, caspase-7 deficient cells could be used to 
reintroduce caspase-7 mutated at the phosphorylation site(s) into these cells and 
assess the effects on caspase-7 activation and trafficking and on the induction of 
apoptosis. 
Finally, The results of this thesis showed that in DT40 cells caspase-6 is dispensable 
for apoptotic cell death and caspase-7 might be involved earlier than other caspases 
in apoptotic execution, yet caspase-7 is not required for cell death. We suggested 
that two sequential signalling cascades are activated in dying DT40 cells (see 
Chapter V Fig 5.11). It would be challenging to investigate whether in signalling 
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cascade 1 (Chapter V Fig 5.11) caspase-7 functions directly in inducing apoptotic 
execution or if instead its role is only to activate downstream caspases. Moreover, it 
will be interesting to investigate if caspase-7 could substitute for the loss of caspase-
3 in both cascades 1 and 2 (Chapter V Fig 5.11). The answer to these questions 
requires the inhibition if caspase-3 function. Ideally this could be done using 
caspase-3 specific inhibitors. However, to date, it is not possible to selectively inhibit 
caspase-3 without affecting caspase-7. Consequently, generating caspase-3 DT40 
cell lines would provide a better understanding of activation mechanisms, interaction 
and the role of the 'effector caspase' family (caspase-3, -6 and —7). Finally, we could 
take advantage of the fact that DT40 cells are ideal to perform multiple gene 
knockouts to further dissect the particular function of each of these caspases during 
the apoptotic process. 
VI D. Closure 
The pathways of apoptosis are constantly being redefined. This complex 
evolutionary mechanism is still far from being completely understood. Clearly, 
components of signalling cascades and other key players in apoptotic execution 
function in a stimulus and context dependent manner, and the specific roles of these 
proteins are still under rigorous investigation. The results presented in this thesis 
provided important new insights into the understanding of caspase-6 and caspase-7 
functions during apoptotic execution. 
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